US 6,607,502 B1Grant

Apparatus and method incorporating an ultrasound transducer onto a delivery member

Issue Date:2003-08-19

•44 Claims

•38 Drawing Sheets

Abstract

A medical device assembly and method provides an ultrasound transducer mounted onto a delivery member, such the elongate body of a catheter shaft, without a support structure bridging between a separation area between the transducer and the shaft. Mounting flanges are extend from either end of the transducer and are mounted at first and second locations along the catheter shaft such that the transducer is suspended over the catheter shaft between those mounting locations. The flanges may be connected by an intermediate member, with the transducer supported on either an outer surface or an inner surface of the intermediate member. The intermediate member may also provide a housing with an enclosed space that houses the transducer, wherein the flanges extend from the housing for mounting to the catheter shaft. In an overall tissue coupling system, a cylindrical ultrasound transducer are mounted onto a catheter shaft by use of such mounting flanges extending from the transducer's ends and such that the ultrasound transducer is enclosed within a balloon also provided on the catheter. The balloon is ideally adapted to engage a circumferential region of tissue where a pulmonary vein extends from an atrium such that the cylindrical ultrasound transducer is able to couple through the balloon inflation fluid and to the circumferential region of tissue surrounding the balloon for ablation. The transducer is substantially “airbacked” when mounted onto a delivery member according to the present assembly and method.

Metadata

Assignee

Atrionix, Inc.

Inventors

Mark A. Maguire
James C. Peacock, III

Application Information

Application Number:US 09/435,280

Filing Date:1999-11-05

Priority Date:1998-11-25

Art Unit:7

Classifications

IPC:

A61B 1720

Field of Search:

606 15606 32606 27606 31606 40606 41606 45606 46606 47606 48607 96607 9960710160710260712260037360037460038160047160410101604 22

Patent Drawings (38 sheets)

Description

Cross-Referenced Claim of Priority to Other Pending U.S. Patent Applications

[0002] This patent application claims priority under 35 U.S.C. 119(e) to Provisional U.S. Patent Application Serial No. 60/133,680, filed on May 11, 1999. In addition, the present application is a continuation-in-part of U.S. application Ser. No. of 09/199,736, filed Nov. 25, 1998, and claims the benefit of priority thereto under 35 U.S.C. §120.

Technical Field

[0003] The present invention is a surgical device and method. More specifically, it is a device assembly and method which provides an ultrasound transducer assembly mounted on a catheter shaft in order to ultrasonically couple to a region of tissue in a body of a patient, and still more specifically to couple to a circumferential region of tissue at a location where a pulmonary vein extends from an atrium in a patient.

Background

[0004] The terms “body space,” including derivatives thereof, is herein intended to mean any cavity or lumen within the body which is defined at least in part by a tissue wall. For example, the cardiac chambers, the uterus, the regions of the gastrointestinal tract, and the arterial or venous vessels are all considered illustrative examples of body spaces within the intended meaning.

[0005] The term “body lumen,” including derivatives thereof, is herein intended to mean any body space which is circumscribed along a length by a tubular tissue wall and which terminates at each of two ends in at least one opening that communicates externally of the body space. For example, the large and small intestines, the vas deferens, the trachea, and the fallopian tubes are all illustrative examples of lumens within the intended meaning. Blood vessels are also herein considered lumens, including regions of the vascular tree between their branch points. More particularly, the pulmonary veins are lumens within the intended meaning, including the region of the pulmonary veins between the branched portions of their ostia along a left ventricle wall, although the wall tissue defining the ostia typically presents uniquely tapered lumenal shapes.

[0006] Many local energy delivery devices and methods have been developed for treating the various abnormal tissue conditions in the body, and particularly for treating abnormal tissue along the body space walls which define the various body spaces in the body. For example, various devices have been disclosed with the primary purpose of treating or recanalizing atherosclerotic vessels with localized energy delivery. Several disclosed devices and methods combine energy delivery assemblies in combination with cardiovascular stent devices in order to locally deliver energy to tissue in order to maintain patency in diseased lumens such as blood vessels. Endometriosis, another abnormal wall tissue condition which is associated with the endometrial cavity of the female and is characterized by dangerously proliferative uterine wall tissue along the surface of the endometrial cavity, has also been treated by local energy delivery devices and methods. Several other devices and methods have also been disclosed which use catheter-based heat sources for the intended purpose of inducing thrombosis and controlling hemorrhaging within certain body lumens such as vessels.

[0007] Further, more detailed examples of local energy delivery devices and related procedures such as those of the types just described above are variously disclosed in the following references: U.S. Pat. No. 4,672,962 to Hershenson; U.S. Pat. No. 4,676,258 to InoKuchi et al.; U.S. Pat. No. 4,790,311 to Ruiz; U.S. Pat. No. 4,807,620 to Strul et al.; U.S. Pat. No. 4,998,933 to Eggers et al.; U.S. Pat. No. 5,035,694 to Kasprzyk et al.; U.S. Pat. No. 5,190,540 to Lee; U.S. Pat. No. 5,226,430 to Spears et al.; and U.S. Pat. No. 5,292,321 to Lee; U.S. Pat. No. 5,449,380 to Chin; U.S. Pat. No. 5,505,730 to Edwards; U.S. Pat. No. 5,558,672 to Edwards et al.; and U.S. Pat. No. 5,562,720 to Stem et al.; U.S. Pat. No. 4,449,528 to Auth et al.; U.S. Pat. No. 4,522,205 to Taylor et al.; and U.S. Pat. No. 4,662,368 to Hussein et al.; U.S. Pat. No. 5,078,736 to Behl; and U.S. Pat. No. 5,178,618 to Kandarpa. The disclosures of these references are herein incorporated in their entirety by reference thereto.

[0008] Other previously disclosed devices and methods electrically couple fluid to an ablation element during local energy delivery for treatment of abnormal tissues. Some such devices couple the fluid to the ablation element for the primary purpose of controlling the temperature of the element during the energy delivery. Other such devices couple the fluid more directly to the tissue-device interface either as another temperature control mechanism or in certain other known applications as an actual carrier for the localized energy delivery, itself.

[0009] More detailed examples of ablation devices which use fluid to assist in electrically coupling electrodes to tissue are disclosed in the following references: U.S. Pat. No. 5,348,554 to Inran et al.; U.S. Pat. No. 5,423,811 to Imran et al.; U.S. Pat. No. 5,505,730 to Edwards; U.S. Pat. No. 5,545,161 to Inran et al.; U.S. Pat. No. 5,558,672 to Edwards et al.; U.S. Pat. No. 5,569,241 to Edwards; U.S. Pat. No. 5,575,788 to Baker et al.; U.S. Pat. No. 5,658,278 to Imran et al.; U.S. Pat. No. 5,688,267 to Panescu et al.; U.S. Pat. No. 5,697,927 to Imran et al.; U.S. Pat. No. 5,722,403 to McGee et al.; U.S. Pat. No. 5,769,846; and PCT Patent Application Publication No. WO 97/32525 to Pomeranz et al.; and PCT Patent Application Publication No. WO 98/02201 to Pomeranz et al. To the extent not previously incorporated above, the disclosures of these references are herein incorporated in their entirety by reference thereto.

[0010] Atrial Fibrillation

[0011] Cardiac arrhythmias, and atrial fibrillation in particular, persist as common and dangerous medical ailments associated with abnormal cardiac chamber wall tissue, and has been observed especially in the aging population. In patients with cardiac arrhythmia, abnormal regions of cardiac tissue do not follow the synchronous beating cycle associated with normally conductive tissue in patients with sinus rhythm. Instead, the abnormal regions of cardiac tissue aberrantly conduct to adjacent tissue, thereby disrupting the cardiac cycle into an asynchronous cardiac rhythm. Such abnormal conduction has been previously known to occur at various regions of the heart, such as, for example, in the region of the sino-atrial (SA) node, along the conduction pathways of the atrioventricular (AV) node and the Bundle of His, or in the cardiac muscle tissue forming the walls of the ventricular and atrial cardiac chambers.

[0012] Cardiac arrhythmias, including atrial arrhythmia, may be of a multiwavelet reentrant type, characterized by multiple asynchronous loops of electrical impulses that are scattered about the atrial chamber and are often self propagating. In the alternative or in addition to the multiwavelet reentrant type, cardiac arrhythmias may also have a focal origin, such as when an isolated region of tissue in an atrium fires autonomously in a rapid, repetitive fashion. Cardiac arrhythmias, including atrial fibrillation, may be generally detected using the global technique of an electrocardiogram (EKG). More sensitive procedures of mapping the specific conduction along the cardiac chambers have also been disclosed, such as, for example, in U.S. Pat. No. 4,641,649 to Walinsky et al. and Published PCT Patent Application No. WO 96/32897 to Desai. The disclosures of these references are herein incorporated in their entirety by reference thereto.

[0013] A host of clinical conditions may result from the irregular cardiac function and resulting hemodynamic abnormalities associated with atrial fibrillation, including stroke, heart failure, and other thromboembolic events. In fact, atrial fibrillation is believed to be a significant cause of cerebral stroke, wherein the abnormal hemodynamics in the left atrium caused by the fibrillatory wall motion precipitate the formation of thrombus within the atrial chamber. A thromboembolism is ultimately dislodged into the left ventricle which thereafter pumps the embolism into the cerebral circulation where a stroke results. Accordingly, numerous procedures for treating atrial arrhythmias have been developed, including pharmacological, surgical, and catheter ablation procedures.

[0014] Several pharmacological approaches intended to remedy or otherwise treat atrial arrhythmias have been disclosed, such as for example according to the disclosures of the following references: U.S. Pat. No. 4,673,563 to Berne et al.; U.S. Pat. No. 4,569,801 to Molloy et al.; and also “Current Management of Arrhythmias” (1991) by Hindricks, et al. However, such pharmacological solutions are not generally believed to be entirely effective in many cases, and are even believed in some cases to result in proarrhythmia and long term inefficacy. The disclosures of these references are herein incorporated in their entirety by reference thereto.

[0015] Several surgical approaches have also been developed with the intention of treating atrial fibrillation. One particular example is known as the “maze procedure,” as is disclosed by Cox, J L et al. in “The surgical treatment of atrial fibrillation. I. Summary” Thoracic and Cardiovascular Surgery101(3), pp. 402-405 (1991); and also by Cox, J L in “The surgical treatment of atrial fibrillation. IV. Surgical Technique”, Thoracic and Cardiovascular Surgery101(4), pp. 584-592 (1991). In general, the “maze” procedure is designed to relieve atrial arrhythmia by restoring effective atrial systole and sinus node control through a prescribed pattern of incisions about the tissue wall. In the early clinical experiences reported, the “maze” procedure included surgical incisions in both the right and the left atrial chambers. However, more recent reports predict that the surgical “maze” procedure may be substantially efficacious when performed only in the left atrium, such as is disclosed in Sueda et al., “Simple Left Atrial Procedure for Chronic Atrial Fibrillation Associated With Mitral Valve Disease” (1996). The disclosure of these cited references are herein incorporated in their entirety by reference thereto.

[0016] The “maze procedure” as performed in the left atrium generally includes forming vertical incisions from the two superior pulmonary veins and terminating in the region of the mitral valve annulus, traversing the region of the inferior pulmonary veins en route. An additional horizontal line also connects the superior ends of the two vertical incisions. Thus, the atrial wall region bordered by the pulmonary vein ostia is isolated from the other atrial tissue. In this process, the mechanical sectioning of atrial tissue eliminates the arrhythmogenic conduction from the boxed region of the pulmonary veins and to the rest of the atrium by creating conduction blocks within the aberrant electrical conduction pathways. Other variations or modifications of this specific pattern just described have also been disclosed, all sharing the primary purpose of isolating known or suspected regions of arrhythmogenic origin or propagation along the atrial wall.

[0017] While the “maze” procedure and its variations as reported by Cox and others have met some success in treating patients with atrial arrhythmia, its highly invasive methodology is believed to be prohibitive in most cases. However, these procedures have provided a guiding principle that electrically isolating faulty cardiac tissue may successfully prevent atrial arrhythmia, and particularly atrial fibrillation caused by arrhythmogenic conduction arising from the region of the pulmonary veins.

[0018] Less invasive catheter-based approaches to treat atrial fibrillation have been disclosed which implement cardiac tissue ablation for terminating arrhythmogenic conduction in the atria. Examples of such catheter-based devices and treatment methods have generally targeted atrial segmentation with ablation catheter devices and methods adapted to form linear or curvilinear lesions in the wall tissue which defines the atrial chambers. Some specifically disclosed approaches provide specific ablation elements which are linear over a defined length intended to engage the tissue for creating the linear lesion. Other disclosed approaches provide shaped or steerable guiding sheaths, or sheaths within sheaths, for the intended purpose of directing tip ablation catheters toward the posterior left atrial wall such that sequential ablations along the predetermined path of tissue may create the desired lesion. In addition, various energy delivery modalities have been disclosed for forming atrial wall lesions, and include use of microwave, laser, ultrasound, thermal conduction, and more commonly, radiofrequency energies to create conduction blocks along the cardiac tissue wall.

[0019] Further more detailed examples of ablation device assemblies and methods for creating lesions along an atrial wall are disclosed in the following U.S. Patent references: U.S. Pat. No. 4,898,591 to Jang et al.; U.S. Pat. No. 5,104,393 to Isner et al.; U.S. Pat. No. 5,427,119; U.S. Pat. No. 5,487,385 to Avitall; U.S. Pat. No. 5,497,119 to Swartz et al.; U.S. Pat. No. 5,545,193 to Fleischman et al.; U.S. Pat. No. 5,549,661 to Kordis et al.; U.S. Pat. No. 5,575,810 to Swanson et al.; U.S. Pat. No. 5,564,440 to Swartz et al.; U.S. Pat. No. 5,592,609 to Swanson et al.; U.S. Pat. No. 5,575,766 to Swartz et al.; U.S. Pat. No. 5,582,609 to Swanson; U.S. Pat. No. 5,617,854 to Munsif; U.S. Pat. No. 5,687,723 to Avitall; U.S. Pat. No. 5,702,438 to Avitall. To the extent not previously incorporated above, the disclosures of these references are herein incorporated in their entirety by reference thereto.

[0020] Other examples of such ablation devices and methods are disclosed in the following Published PCT Patent Applications: WO 93/20767 to Stem et al.; WO 94/21165 to Kordis et al.; WO 96/10961 to Fleischman et al.; WO 96/26675 to Klein et al.; and WO 97/37607 to Schaer. To the extent not previously incorporated above, the disclosures of these references are herein incorporated in their entirety by reference thereto.

[0021] Additional examples of such ablation devices and methods are disclosed in the following published articles: “Physics and Engineering of Transcatheter Tissue Ablation”, Avitall et al., Journal of American College of Cardiology,Volume 22, No. 3:921-932 (1993); and “Right and Left Atrial Radiofrequency Catheter Therapy of Paroxysmal Atrial Fibrillation,” Haissaguerre, et al., Journal of Cardiovascular Electrophysiology7(12), pp. 1132-1144 (1996). The disclosures of these references are herein incorporated in their entirety by reference thereto.

[0022] In addition to those known assemblies just summarized above, additional tissue ablation device assemblies have also been recently developed for the specific purpose of ensuring firm contact and consistent positioning of a linear ablation element along a length of tissue by anchoring the element at least at one predetermined location along that length, such as in order to form a “maze”-type lesion pattern in the left atrium. One example of such assemblies includes an anchor at each of two ends of a linear ablation element in order to secure those ends to each of two predetermined locations along a left atrial wall, such as at two adjacent pulmonary veins, so that tissue may be ablated along the length of tissue extending therebetween.

[0023] In addition to attempting atrial wall segmentation with long linear lesions for treating atrial arrhythmia, other ablation device and method have also been disclosed which are intended to use expandable members such as balloons to ablate cardiac tissue. Some such devices have been disclosed primarily for use in ablating tissue wall regions along the cardiac chambers. Other devices and methods have been disclosed for treating abnormal conduction of the left-sided accessory pathways, and in particular associated with “Wolff-Parkinson-White” syndrome various such disclosures use a balloon for ablating from within a region of an associated coronary sinus adjacent to the desired cardiac tissue to ablate. Further more detailed examples of devices and methods such as of the types just described are variously disclosed in the following published references: Fram et al., in “Feasibility of RF Powered Thermal Balloon Ablation of Atrioventricular Bypass Tracts via the Coronary Sinus: In vivo Canine Studies,” PACE,Vol. 18, p 1518-1530 (1995); “Long-term effects of percutaneous laser balloon ablation from the canine coronary sinus”, Schuger CD et al., Circulation(1992) 86:947-954; and “Percutaneous laser balloon coagulation of accessory pathways”, McMath L P et al., Diagn Ther Cardiovasc Interven 1991; 1425:165-171. The disclosures of these references are herein incorporated in their entirety by reference thereto.

[0024] Arrhythmias Originating from Foci in Pulmonary Veins

[0025] Various modes of atrial fibrillation have also been observed to be focal in nature, caused by the rapid and repetitive firing of an isolated center within cardiac muscle tissue associated with the atrium. Such foci may act as either a trigger of atrial fibrillatory paroxysmal or may even sustain the fibrillation. Various disclosures have suggested that focal atrial arrhythmia often originates from at least one tissue region along one or more of the pulmonary veins of the left atrium, and even more particularly in the superior pulmonary veins.

[0026] Less-invasive percutaneous catheter ablation techniques have been disclosed which use end-electrode catheter designs with the intention of ablating and thereby treating focal arrhythmias in the pulmonary veins. These ablation procedures are typically characterized by the incremental application of electrical energy to the tissue to form focal lesions designed to terminate the inappropriate arrhythmogenic conduction.

[0027] One example of a focal ablation method intended to treat focal arrhythmia originating from a pulmonary vein is disclosed by Haissaguerre, et al. in “Right and Left Atrial Radiofrequency Catheter Therapy of Paroxysmal Atrial Fibrillation” in Journal of Cardiovascular Electrophysiology7(12), pp. 1132-1144 (1996) (previously incorporated by reference above). Haissaguerre, et al. discloses radiofrequency catheter ablation of drug-refractory paroxysmal atrial fibrillation using linear atrial lesions complemented by focal ablation targeted at arrhythmogenic foci in a screened patient population. The site of the arrhythmogenic foci were generally located just inside the superior pulmonary vein, and the focal ablations were generally performed using a standard 4 mm tip single ablation electrode.

[0028] Another focal ablation method of treating atrial arrhythmias is disclosed in Jais et al., “A focal source of atrial fibrillation treated by discrete radiofrequency ablation,” Circulation95:572-576 (1997). The disclosure of this reference is herein incorporated in its entirety by reference thereto. Jais et al. discloses treating patients with paroxysmal arrhythmias originating from a focal source by ablating that source. At the site of arrhythmogenic tissue, in both right and left atria, several pulses of a discrete source of radiofrequency energy were applied in order to eliminate the fibrillatory process.

[0029] Other assemblies and methods have been disclosed addressing focal sources of arrhythmia in pulmonary veins by ablating circumferential regions of tissue either along the pulmonary vein, at the ostium of the vein along the atrial wall, or encircling the ostium and along the atrial wall. More detailed examples of device assemblies and methods for treating focal arrhythmia as just described are disclosed in Published PCT Patent Application No. WO 99/02096 to Diederich et al., and also in the following pending U.S. Patent Applications: U.S. Ser. No. 08/889,798 for “Circumferential Ablation Device Assembly” to Michael D. Lesh et al., filed Jul. 8, 1997; U.S. Ser. No. 08/889,835 for “Device and Method for Forming a Circumferential Conduction Block in a Pulmonary Vein” to Michael D. Lesh, filed Jul. 8, 1997; U.S. Ser. No. 09/199,736 for “Circumferential Ablation Device Assembly” to Chris J. Diederich et. al., filed Feb. 3, 1998; and U.S. Ser. No. 09/260,316 for “Device and Method for Forming a Circumferential Conduction Block in a Pulmonary Vein” to Michael D. Lesh.

[0030] Another specific device assembly and method which is intended to treat focal atrial fibrillation by ablating a circumferential region of tissue between two seals in order to form a conduction block to isolate an arrhythmogenic focus within a pulmonary vein is disclosed in U.S. Pat. No. 5,938,660 and a related Published PCT Patent Application No. WO 99/00064. The disclosures of these references are herein incorporated in their entirety by reference thereto

[0031] In particular, certain tissue ablation device assemblies which incorporate ultrasound energy sources to tissue have been observed to be highly efficient and effective for ablating such circumferential regions of tissue where pulmonary veins extend from atria. However, the efficiency of ultrasonic output from such a source has been observed to be directly related to the structural coupling of the transducer to the underlying delivery member or catheter shaft. The transducer is damped whenever it is in contact with any sort of mounting means between the back or inner side of the transducer and the catheter shaft, even according to known modes using elastomeric mounting structures sandwiched between the transducer and the shaft, though to a reduced extent. Several known ultrasound transducer mounting examples provide support structures that extend between the transducer and the underlying support member, such that for example the transducer rests on the support member which rests on the delivery member. Further more detailed examples of such ultrasound transducer support structures are disclosed in the following references: U.S. Pat. No. 5,606,974 to Castellano; and U.S. Pat. No. 5,620,479 to Diederich. The disclosures of these references are herein incorporated in their entirety by reference thereto. Further examples of structural support designs for ultrasound transducers on catheter shafts are disclosed in published PCT Patent Application PCT/U.S.98/09554 (WO98/49957) to Diederich et al.

[0032] Further to the previously disclosed ultrasound transducer mounting structures and arrangements, it is desirable for any such mounting structure to provide sufficient support and positioning for the transducer, and also provide for air backing between the transducer and the underlying delivery shaft in order to isolate ultrasound transmission radially away from the catheter shaft and toward tissue surrounding the shaft. In addition, it has further been observed that such airbacking helps prevent heat build-up in the region, as the vibrational ultrasound energy has been observed to superheat other materials in contact therewith which absorb the energy (airbacking actually reflects the energy radially outwardly as desired). Such needs for airbacking are believed to be particularly true for high operational powers associated with therapeutic ultrasound ablation transmission, as opposed to the much lower power diagnostic ultrasound assemblies which are often fixed to delivery members without any airbacking (not nearly enough energy to do the kind of material damage a therapeutic ablation energy source emits). In view of these desires, it is further desired to support the transducer as described although while minimizing the vibrational damping of the transducer during operation.

Summary of the Invention

[0033] This invention provides various catheter constructions and associated methods of manufacture for mounting an ultrasound transducer onto a catheter shaft and while minimizing the damping of the transducer associated with the structural coupling to the shaft. In several of the construction variations, the transducer is suspended about an inner member (e.g., the catheter shaft) absent any support structure between the inner member and the transducer along the length of the transducer. That is, transducer mounting is accomplished without the use of internal mounting members and/or elastic member between the inner member and the transducer. Such mounting arrangements support the transducer and are attached to the inner member (or to an assembly of members) at points proximal and distal of the ultrasound transducer.

[0034] The embodiments of the invention are also generally adapted to capture air, or another gas as would be apparent to one of ordinary skill, within the mounting structures in order to “air back” the transducer. That is, these modes of suspension maintain an air gap between the transducer and the catheter shaft in order to maximize radially outward propagation of the ultrasound waves, as introduced above. In addition, the air space desirably is sealed to prevent fluid infiltration, be it blood or water.

[0035] Therefore, according to one mode of the invention, a tissue ablation system includes an ultrasound ablation element mounted on a distal end portion of a delivery member such as an elongate catheter body. A radial separation defines a radial separation area between the ultrasound ablation element and the distal end portion. Further to this mode, the ablation element is mounted onto the catheter shaft without a support structure extending across the radial separation area between the ultrasound ablation element and the catheter shaft.

[0036] In one aspect of this mode, a gas is captured within the radial separation area, and the radial separation area may also be sealed to substantially prevent an external fluid from entering the radial separation area, such as blood or another fluid.

[0037] In another aspect of this mode, the ultrasound ablation element is adapted to ablate a circumferential region of tissue at a location where a pulmonary vein extends from an atrium in a patient.

[0038] In another aspect of this mode, the ultrasound ablation element provides a cylindrical ultrasound transducer that has an inner surface that forms an inner bore. The inner surface is positioned over and around the distal end portion such that the radial separation area is located between the inner surface and the distal end portion.

[0039] In another aspect of this mode, the ultrasound ablation element uses a piezoceramic ultrasound transducer, wherein according to another aspect the ultrasound ablation element provides an array of ultrasound transmissive panels.

[0040] In another aspect of this mode, an external cover layer is disposed around the ultrasound ablation element and distal end portion such that the ultrasound ablation element is positioned between the external cover layer and the distal end portion. In one variation of this aspect, this external cover layer includes an adhesive. In another variation, the cover layer provides an external cover member that surrounds the ultrasound ablation element, and also provides an adhesive layer between the cover member and the ultrasound ablation element. In still a further variation, one end of the external cover layer is secured to the underlying catheter body distally of the ultrasound ablation element, and the other end of the external cover layer is secured to the catheter body proximally of the ultrasound ablation element.

[0041] In another aspect of this mode, the ultrasound ablation element comprises first and second end portions, first and second mounting flanges extend axially from said first and second end portions, respectively, relative to the longitudinal axis, and the first and second mounting flanges are secured to the distal end portion at first and second locations, respectively, which are outside of the radial separation area. According to one variation of this aspect, one or more end caps, which may beneficially be polymeric or elastomeric, may be provided between the flanges and the catheter shaft. In another variation, the mounting flanges provide a recess on one end which engages the ultrasound ablation element. Still further, the first and second mounting flanges may be connected, such as for example in one beneficial design where the flanges extend from an integral overall housing or shell or structure bridging across the length of the ultrasound transducer.

[0042] In another aspect of this mode, a tubular member is used to mount the transducer to the catheter body. The tubular member's ends are secured to first and second locations, respectively, along the catheter body, and the ultrasound ablation element is secured to the exterior surface of an intermediate portion between the two ends of the tubular member.

[0043] In another aspect of this mode, an expandable member is also located along the distal end portion of the elongate catheter body. In one variation of this aspect, an outer wall of the expandable member encloses the ultrasound ablation element mounted onto the catheter shaft body. Further to this aspect, the transducer is adapted to ultrasonically couple to tissue engaged by the expandable member's outer wall when expanded. In further more detailed variation, the expandable member and ablation element are specifically s adapted to engage and ablate a circumferential region of tissue at a location where a pulmonary vein extends from an atrium in a patient.

[0044] In still a further aspect of this mode, a mounting assembly is coupled to the ultrasound ablation element and also to the distal end portion at at least one other location which is outside of the radial separation area. The mounting assembly according to this aspect mounts the ultrasound ablation element onto the distal end portion without extending radially across the radial separation area between the distal end portion and the ultrasound ablation element.

[0045] Another mode of the invention provides a particular ultrasound transducer assembly for use with a delivery member in a tissue ablation system. The assembly includes a cylindrical ultrasound transducer coupled to a mounting assembly with a first mounting flange extending from one end of the transducer and a second mounting flange extending from a second end of the transducer. The first and second mounting flanges are adapted to be secured to the delivery member in order to mount the cylindrical ultrasound transducer to the delivery member to form at least in part a tissue ablation device assembly.

[0046] In one aspect of this mode, the first and second mounting flanges are connected. According to one particular variation of this aspect, the mounting assembly provides a mounting member with an intermediate portion coupled to the cylindrical ultrasound transducer, and two opposite end portions extending beyond the transducer's ends for mounting onto a catheter shaft. In still a further variation, the intermediate portion of the mounting member surrounds the outside of the cylindrical ultrasound transducer. The transducer may be secured to and suspended inwardly from an inner surface of that intermediate portion such that by securing the mounting member's ends to the underlying catheter shaft the transducer is held over and around the shaft. In yet another variation, it is the cylindrical transducer that surrounds the intermediate portion of the mounting member. According to another mounting member variation, the cylindrical ultrasound transducer is housed within a cylindrical space formed between outer and inner layers along the intermediate portion of the mounting member.

[0047] According to another aspect of this mode, the mounting flanges are tubular members which have a reduced diameter section at one end with a smaller inner diameter than the outer diameter of the cylindrical ultrasound transducer. The reduced diameter section is adapted to be secured around the delivery member.

[0048] Another mode of the invention provides a method for manufacturing a tissue ablation device assembly. According to this method, first and second mounting flanges are mounted to first and second ends, respectively, of a cylindrical ultrasound transducer. The flanges are also mounted to first and second locations, respectively, along a distal end portion of a delivery member such that the cylindrical ultrasound transducer is between and does not extend over the first and second locations.

[0049] According to various aspects of this method mode, one or both of the mounting flanges may be mounted to the transducer either before or after mounting to the delivery member. In another aspect, the mounting flanges are connected by an intermediate member which is mounted to the cylindrical ultrasound transducer.

[0050] Another mode of the invention provides a method for manufacturing an ultrasound transducer assembly for use with a delivery member in a tissue ablation system. According to this method mode, first and second mounting flanges are mounted to opposite ends of a cylindrical ultrasound transducer such that the flanges extend from the transducer's ends in order to be secured to the delivery member to thereby mount the cylindrical ultrasound transducer to the delivery member and form, at least in part, a tissue ablation device assembly.

[0051] According to one further aspect of this mode, the first and second mounting flanges are connected along the cylindrical ultrasound transducer.

[0052] According to various additional aspects, the mounting flanges may be mounted to the ultrasound transducer either at the same time or in series, and the mounting flanges may also be connected, such as by being different parts of one common member.

[0053] In another aspect of this mode, the cylindrical ultrasound transducer is located within a housing from which the mounting flanges extend, wherein the mounting flanges may be separate members attached to the housing or may be formed integrally with at least a portion of the housing.

[0054] In still a further aspect of the cylindrical ultrasound transducer according to this method mode, the transducer is formed from an array of ultrasound transducer panels which may be actuatable together or, in a particular embodiment, separately.

[0055] The mounting flanges of this method mode may also be tubular such that they are adapted to mount at one end to the circumference of the cylindrical ultrasound transducer and at the other end over and around an underlying catheter shaft.

[0056] According to further beneficial embodiments, the ultrasound transducer apparatus and method modes just summarized are applied in a circumferential ablation device assembly which is adapted to couple to and ablate a circumferential region of tissue at a location where a pulmonary vein extends from an atrium. Moreover, the modes described for use with a circumferential ultrasound transducer may also be adapted for use with non-circumferential types of transducers, such as incorporating panel transducers that also benefit by being air backed without mounting members physically located and extending between such transducers and an underlying catheter shaft.

Brief Description of the Drawings

[0057] FIG. 1 diagrammatically shows sequential, general steps for treating atrial arrhythmia.

[0058] FIGS. 2A-E show schematic, perspective views of various exemplary circumferential conduction blocks formed in pulmonary vein wall tissue with a circumferential ablation device assembly.

[0059] FIG. 3 shows a flow diagram of a method for using s circumferential ablation device assembly.

[0060] FIG. 4 shows a perspective view of a circumferential ablation device assembly during use in a left atrium subsequent to performing transeptal access and guidewire positioning steps according to the method of FIG. 3.

[0061] FIG. 5 shows a similar perspective view of the circumferential ablation device assembly shown in FIG. 4, and further shows a circumferential ablation catheter during use in ablating a circumferential region of tissue along a pulmonary vein wall to form a circumferential conduction block in the pulmonary vein according to the method of FIG. 3.

[0062] FIG. 6A shows a similar perspective view as shown in FIG. 5, although showing a further circumferential ablation catheter variation which is adapted to allow for blood perfusion from the pulmonary vein and into the atrium while performing the circumferential ablation method shown diagrammatically in FIG. 3.

[0063] FIG. 6B is an enlarged partial view of the circumferential ablation catheter shown in FIG. 6A, with a perfusion lumen shown in phantom.

[0064] FIG. 7 shows a similar perspective view of the left atrium as that shown in FIGS. 3-5, although showing a cross-sectional view of a circumferential lesion after being formed by circumferential catheter ablation according to the method of FIG. 3.

[0065] FIGS. 8A-B show perspective views of another circumferential ablation catheter variation during use in a left atrium according to the method of FIG. 3, wherein FIG. 8A shows a radially compliant expandable member with a working length adjusted to a radially expanded position while in the left atrium, and FIG. 8B shows the expandable member after advancing it into and engaging a pulmonary vein ostium while in the radially expanded position.

[0066] FIG. 8C shows the same perspective view of the left atrium shown in FIGS. 8A-B, although shown after forming a circumferential conduction block according to the circumferential ablation procedure of FIG. 3 and also after removing the circumferential ablation device assembly from the left atrium.

[0067] FIG. 8D shows another circumferential ablation catheter during use in a left atrium, and shows an expandable member in a radially expanded position which is engaged within a pulmonary vein ostium such that a circumferential band of a circumferential ablation element circumscribing the expandable member is also engaged to a circumferential path of tissue along the left posterior atrial wall which surrounds the pulmonary vein ostium.

[0068] FIG. 8E shows one particular expandable member and circumferential ablation element which is adapted for use according to the mode of use shown in FIG. 8D.

[0069] FIG. 8F shows a resulting circumferential conduction block or lesion which may be formed with the assemblies shown in FIGS. 8D-E and according to the method of use shown in FIG. 8D.

[0070] FIG. 9A diagrammatically shows a method for using a circumferential ablation device assembly to form a circumferential conduction block in a pulmonary vein in combination with a method for forming long linear lesions between pulmonary vein ostia in a less-invasive “maze” -type procedure.

[0071] FIG. 9B shows a perspective view of a segmented left atrium after forming several long linear lesions between adjacent pairs of pulmonary vein ostia according to the method of FIG. 9A.

[0072] FIG. 9C shows a similar perspective view as that shown in FIG. 9B, although showing a circumferential ablation device assembly during use in forming a circumferential lesion in a pulmonary vein which intersects with two linear lesions that extend into the pulmonary vein, according to the method of FIG. 9A.

[0073] FIG. 9D shows a perspective view of another ablation catheter which combines a linear ablation member extending between two anchors with a circumferential ablation member for use in forming a circumferential lesion which intersects with at least one linear lesion according to the method of FIG. 9A.

[0074] FIG. 9E shows a perspective view of another circumferential ablation catheter for use in forming a circumferential lesion which intersects with at least one linear lesion according to the method of FIG. 9A.

[0075] FIG. 9F shows a perspective view of a segmented left posterior atrial wall with a lesion pattern which results from combining the formation of two linear lesions according to FIG. 9B with the formation of a circumferential conduction block according to the methods and devices shown in FIGS. 8A-C.

[0076] FIG. 9G shows a perspective view of a segmented left posterior atrial wall with a lesion pattern which results from combining the formation of two linear lesions according to FIG. 9B with the formation of a circumferential conduction block according to the methods and devices shown in FIGS. 8D-F.

[0077] FIG. 9H shows a schematic perspective view of a left posterior atrial wall with one complete lesion pattern in a variation of a less-invasive “maze”-type procedure wherein circumferential conduction blocks are formed along circumferential paths of tissue along a left posterior atrial wall such that each circumferential conduction block surrounds a pulmonary vein ostium, each pair of vertically adjacent circumferential conduction blocks intersects, and each pair of horizontally adjacent circumferential conduction blocks are connected with one of two linear lesions extending between the respective pair of horizontally adjacent pulmonary vein ostia.

[0078] FIG. 10 diagrammatically shows a further method for using the circumferential ablation device assembly of the present invention to form a circumferential conduction block in a pulmonary vein wall, wherein signal monitoring and “post-ablation” test elements are used to locate an arrhythmogenic origin along the pulmonary vein wall and to test the efficacy of a circumferential conduction block in the wall, respectively.

[0079] FIGS. 11A-B show perspective views of another circumferential ablation member variation for use in a circumferential ablation device assembly for pulmonary vein isolation, showing a circumferential ablation electrode circumscribing the working length of an expandable member with a secondary shape along the longitudinal axis of the working length which is a modified step shape, the expandable member being shown in a radially collapsed position and also in a radially expanded position, respectively.

[0080] FIGS. 11C-D show perspective views of two circumferential ablation electrodes which form equatorial or otherwise circumferentially placed bands that circumscribe the working length of an expandable member and that have serpentine and sawtooth secondary shapes, respectively, relative to the longitudinal axis of the expandable member when adjusted to a radially expanded position.

[0081] FIGS. 12A-B show perspective views of another circumferential ablation element which includes a plurality of individual ablation electrodes that are spaced circumferentially to form an equatorial band which circumscribes the working length of an expandable member either in an equatorial location or an otherwise circumferential location that is bounded both proximally and distally by the working length, and which are adapted to form a continuous circumferential lesion while the working length is adjusted to a radially expanded position.

[0082] FIG. 13 shows a cross-sectional view of another circumferential ablation member for use in a circumferential ablation device assembly for pulmonary vein isolation, wherein the circumferential ablation element circumscribes an outer surface of an expandable member substantially along its working length and is insulated at both the proximal and the distal ends of the working length to thereby form an uninsulated equatorial band in a middle region of the working length or otherwise circumferential region of the working length which is bounded both proximally and distally by end portions of the working length, which member is adapted to ablate a circumferential path of tissue engaged by the equatorial band.

[0083] FIG. 14 shows a perspective view of another circumferential ablation member which is adapted for use in a circumferential ablation device assembly for pulmonary vein isolation, wherein the expandable member is shown to be a cage of coordinating wires which are adapted to be adjusted from a radially collapsed position to a radially expanded position in order to engage electrode elements on the wires about a circumferential pattern of tissue to be ablated.

[0084] FIG. 15 shows a cross-sectional view of another circumferential ablation element which is adapted for use in a circumferential ablation device assembly for pulmonary vein isolation. A superelastic, looped electrode element is shown at the distal end of a pusher and is adapted to circumferentially engage pulmonary vein wall tissue to form a circumferential lesion as a conduction block that circumscribes the pulmonary vein lumen.

[0085] FIG. 16A shows a longitudinal cross-sectional view of another circumferential ablation catheter, and shows the ablation element to include a single cylindrical ultrasound transducer which is positioned along an inner member within an expandable balloon which is further shown in a radially expanded condition.

[0086] FIG. 16B shows a transverse cross-sectional view of the circumferential ablation catheter shown in FIG. 16A taken along line 16B-16B shown in FIG. 16A.

[0087] FIG. 16C shows a transverse cross-sectional view of the circumferential ablation catheter shown in FIG. 16A taken along line 16C-16C shown in FIG. 16A.

[0088] FIG. 16D shows a perspective view of the ultrasonic transducer of FIG. 16A in isolation.

[0089] FIG. 16E shows a modified version of the ultrasonic transducer of FIG. 16D with individually driven sectors.

[0090] FIG. 17A shows a perspective view of a similar circumferential ablation catheter to the catheter shown in FIG. 16A, and shows the distal end portion of the circumferential ablation catheter during one mode of use in forming a circumferential conduction block in a pulmonary vein in the region of its ostium along a left atrial wall (shown in cross-section in shadow).

[0091] FIG. 17B shows a similar perspective and cross-section shadow view of a circumferential ablation catheter and pulmonary vein ostium as that shown in FIG. 17A, although shows another circumferential ablation catheter wherein the balloon has a tapered outer diameter.

[0092] FIG. 17C shows a similar view to that shown in FIGS. 17A-B, although showing another circumferential ablation catheter wherein the balloon has a “pear”-shaped outer diameter with a contoured surface along a taper which is adapted to seat in the ostium of a pulmonary vein.

[0093] FIG. 17D shows a cross-sectional view of one circumferential conduction block which may be formed by use of a circumferential ablation catheter such as that shown in FIG. 17C.

[0094] FIG. 18A shows a cross-sectional view of the distal end portion of another circumferential ablation catheter, wherein an outer shield or filter is provided along the balloon's outer surface in order to form a predetermined shape for the circumferential ablation element created by sonic transmissions from the inner ultrasound transducer.

[0095] FIG. 18B shows a similar view as that shown in FIG. 18A, although showing the distal end portion of another circumferential ablation catheter which includes a heat sink as an equatorial band within the circumferential path of energy emission from an inner ultrasound transducer.

[0096] FIG. 19A shows a transverse cross-sectional view of an additional circumferential ablation catheter for pulmonary vein isolation, and shows the ablation element to include a single transducer sector segment which is positioned along an inner member within an expandable balloon which is further shown in a radially expanded condition.

[0097] FIG. 19B shows a transverse cross-sectional view of an a further circumferential ablation catheter adapted for use in isolating a pulmonary vein, and shows the ablation element to include a single curvilinear section that is mounted so as to position its concave surface facing in a radially outward direction.

[0098] FIG. 20A is a perspective view of one embodiment of the suspended coaxial transducer.

[0099] FIG. 20B is a cross-sectional view through the transducer (line B—B).

[0100] FIG. 21A is a perspective view showing another embodiment of the suspended coaxial transducer having a thin molded shell.

[0101] FIG. 21B shows the transducer in a molded shell in transverse section along plane B—B of FIG. 21A.

[0102] FIG. 22 shows another variation of the mounting design having a support sleeve and shrink-wrap cover.

[0103] FIG. 23 shows another variation of the design for mounting the molded transducer having an O-ring and shrink-wrap cover.

[0104] FIG. 24 shows another variation of the suspended coaxial transducer having pre-formed end mounts.

[0105] FIG. 25A shows a mounting balloon variation of the suspended coaxial transducer.

[0106] FIG. 25B is a perspective view of the sequence of making the balloon mounted transducer shown in FIG. 25A.

[0107] FIG. 26 is a partial cross-sectional view of a transducer supported on a support member that is mounted on a tracking member of a catheter assembly.

[0108] FIG. 27 is a perspective view of the support illustrated in FIG. 26.

[0109] FIG. 28A is a side view of the support of FIG. 27.

[0110] FIG. 28B is a end view of the support of FIG. 27.

[0111] FIG. 29A shows a perspective view of another transducer mounted onto a tracking member of a catheter assembly according to the invention.

[0112] FIG. 29B shows a longitudinal cross-sectional view taken along lines 29B—29B in FIG. 29A.

[0113] FIG. 29C shows a transverse cross-sectional view taken along lines 29C—29C in FIG. 29A.

[0114] FIG. 29D shows a longitudinal cross-sectional view of a transducer mounted onto a tracking member of a catheter assembly according to an embodiment of the present invention.

Detailed Description of the Preferred Embodiments

[0115] As will be described with reference to the detailed embodiments below, the modes for mounting a circumferential ultrasound ablation element to a catheter shaft according to the present invention are believed to be well suited for use in a circumferential ablation device assembly which is adapted to treat patients with atrial arrhythmia by ablating a circumferential region of tissue at a location where a pulmonary vein extends from an atrium, such as (a) where cardiac tissue extends up into the vein; or (b) along the vein's ostium along the atrial wall; or (c) along the atrial wall and surrounding the vein's ostium. By ablating such a circumferential region of tissue, a circumferential conduction block is formed which either isolates the atrium from an arrhythmogenic focus upstream of the conduction block relative to the vein, or ablates the focus. This circumferential pulmonary vein ablation aspect of the invention is therefore suited for combination or aggregation with, or where appropriate in substitution for, the various features and embodiments disclosed in the following co-pending U.S. Patent Applications that also address circumferential ablation at a location where a pulmonary vein extends from an atrium: U.S. Ser. No. 08/889,798 for “CIRCUMFERENTIAL ABLATION DEVICE ASSEMBLY” to Michael D. Lesh et al., filed Jul. 8, 1997; U.S. Ser. No. 08/889,835 for “DEVICE AND METHOD FOR FORMING A CIRCUMFERENTIAL CONDUCTION BLOCK IN A PULMONARY VEIN” to Michael D. Lesh, filed Jul. 8, 1997; U.S. Ser. No. 09/199,736 for “CIRCUMFERENTIAL ABLATION DEVICE ASSEMBLY” to Chris J. Diederich et al., filed Feb. 3, 1998; and U.S. Ser. No. 09/260,316 for “DEVICE AND METHOD FOR FORMING A CIRCUMFERENTIAL CONDUCTION BLOCK IN A PULMONARY VEIN” to Michael D. Lesh. The disclosures of these references are herein incorporated in their entirety by reference thereto. For the purpose of further illustration, however, particular embodiments for pulmonary vein isolation are shown and described by reference to FIGS. 1-19B, with the related method of treatment broadly illustrated in diagrammatical form in the flow diagram of FIG. 1.

[0116] The terms “circumference” or “circumferential”, including derivatives thereof, are herein intended to mean a continuous path or line which forms an outer border or perimeter that surrounds and thereby defines an enclosed region of space. Such a continuous path starts at one location along the outer border or perimeter, and translates along the outer border or perimeter until it is completed at the original starting location to enclose the defined region of space. The related term “circumscribe,” including derivatives thereof, is herein intended to mean to enclose, surround, or encompass a defined region of space. Therefore, according to these defined terms, a continuous line which is traced around a region of space and which starts and ends at the same location “circumscribes” the region of space and has a “circumference” which is defined by the distance the line travels as it translates along the path circumscribing the space.

[0117] Still further, a circumferential path or element may include one or more of several shapes, and may be, for example, circular, oblong, ovular, elliptical, or otherwise planar enclosures. A circumferential path may also be three dimensional, such as, for example, two opposite-facing semi-circular paths in two different parallel or off-axis planes which are connected at their ends by line segments bridging between the planes.

[0118] For purpose of further illustration, FIGS. 2A-D therefore show various circumferential paths A, B, C, and D, respectively, each translating along a portion of a pulmonary vein wall and circumscribing a defined region of space, shown at a, b, c, and d also respectively, each circumscribed region of space being a portion of a pulmonary vein lumen. For still further illustration of the three-dimensional circumferential case shown in FIG. 2D, FIG. 2E shows an exploded perspective view of circumferential path D as it circumscribes multiplanar portions of the pulmonary vein lumen shown at d′, d″, and d′″, which together make up region d as shown in FIG. 2D.

[0119] The term “transect”, including derivatives thereof, is also herein intended to mean to divide or separate a region of space into isolated regions. Thus, each of the regions circumscribed by the circumferential paths shown in FIGS. 2A-D transects the respective pulmonary vein, including its lumen and its wall, to the extent that the respective pulmonary vein is divided into a first longitudinal region located on one side of the transecting region, shown, for example, at region “X” in FIG. 2A, and a second longitudinal region on the other side of the transecting plane, shown, for example, at region “Y” also in FIG. 2A.

[0120] Therefore, a “circumferential conduction block” according to the present invention is formed along a region of tissue which follows a circumferential path along the pulmonary vein wall, circumscribing the pulmonary vein lumen and transecting the pulmonary vein relative to electrical conduction along its longitudinal axis. The transecting circumferential conduction block therefore isolates electrical conduction between opposite longitudinal portions of the pulmonary wall relative to the conduction block and along the longitudinal axis.

[0121] The terms “ablate” or “ablation,” including derivatives thereof, are hereafter intended to mean the substantial altering of the mechanical, electrical, chemical, or other structural nature of tissue. In the context of intracardiac ablation applications shown and described with reference to the variations of the illustrative embodiment below, “ablation” is intended to mean sufficient altering of tissue properties to substantially block conduction of electrical signals from or through the ablated cardiac tissue.

[0122] The term “element” within the context of “ablation element” is herein intended to mean a discrete element, such as an electrode, or a plurality of discrete elements, such as a plurality of spaced electrodes, which are positioned so as to collectively ablate a region of tissue.

[0123] Therefore, an “ablation element” according to the defined terms may include a variety of specific structures adapted to ablate a defined region of tissue. For example, one suitable ablation element for use in the present invention may be formed, according to the teachings of the embodiments below, from an “energy emitting” type which is adapted to emit energy sufficient to ablate tissue when coupled to and energized by an energy source. Suitable “energy emitting” ablation elements for use in the present invention may therefore include, for example: an electrode element adapted to couple to a direct current (“DC”) or alternating current (“AC”) current source, such as a radiofrequency (“RF”) current source; an antenna element which is energized by a microwave energy source; a heating element, such as a metallic element or other thermal conductor which is energized to emit heat such as by convective or conductive heat transfer, by resistive heating due to current flow, or by optical heating with light; a light emitting element, such as a fiber optic element which transmits light sufficient to ablate tissue when coupled to a light source; or an ultrasonic element such as an ultrasound crystal element which is adapted to emit ultrasonic sound waves sufficient to ablate tissue when coupled to a suitable excitation source.

[0124] In addition, other elements for altering the nature of tissue may be suitable as “ablation elements” under the present invention when adapted according to the detailed description of the invention below. For example, a cryoablation element adapted to sufficiently cool tissue to substantially alter the structure thereof may be suitable if adapted according to the teachings of the current invention. Furthermore, a fluid delivery element, such as a discrete port or a plurality of ports which are fluidly coupled to a fluid delivery source, may be adapted to infuse an ablating fluid, such as a fluid containing alcohol, into the tissue adjacent to the port or ports to substantially alter the nature of that tissue.

[0125] The term “diagnose”, including derivatives thereof, is intended to include patients suspected or predicted to have atrial arrhythmia, in addition to those having specific symptoms or mapped electrical conduction indicative of atrial arrhythmia.

[0126] Returning to the inventive method as shown in FIG. 1, a patient diagnosed with atrial arrhythmia according to diagnosing step (1) is treated with a circumferential conduction block according to treatment step (2). In one aspect, a patient diagnosed according to diagnosis step (1) with multiple wavelet arrhythmia originating from multiple regions along the atrial wall may also be treated in part by forming the circumferential conduction block according to treatment step (2), although as an adjunct to forming long linear regions of conduction block between adjacent pulmonary vein ostia in a less-invasive “maze”-type catheter ablation procedure. More detail regarding this particular aspect of the inventive method is provided below with reference to a combination circumferential-long linear lesion ablation device which is described below with reference to FIGS. 9A-F.

[0127] In another aspect of the method of FIG. 1, a patient diagnosed with focal arrhythmia originating from an arrhythmogenic origin or focus in a pulmonary vein is treated according to this method when the circumferential conduction block is formed along a circumferential path of wall tissue that either includes the arrhythmogenic origin or is between the origin and the left atrium. In the former case, the arrhythmogenic tissue at the origin is destroyed by the conduction block as it is formed through that focus. In the latter case, the arrhythmogenic focus may still conduct abnormally, although such aberrant conduction is prevented from entering and affecting the atrial wall tissue due to the intervening circumferential conduction block.

[0128] In still a further aspect of the method shown in FIG. 1, the circumferential conduction block may be formed in one of several ways according to treatment step (2). In one example not shown, the circumferential conduction block may be formed by a surgical incision or other method to mechanically transect the pulmonary vein, followed by suturing the transected vein back together. As the circumferential injury is naturally repaired, such as through a physiologic scarring response common to the “maze” procedure, electrical conduction will generally not be restored across the injury site. In another example not shown, a circumferential conduction block of one or more pulmonary veins may be performed in an epicardial ablation procedure, wherein an ablation element is either placed around the target pulmonary vein or is translated circumferentially around it while being energized to ablate the adjacent tissue in an “outside-in” approach. This alternative method may be performed during an open chest-type procedure, or may be done using other known epicardial access techniques.

[0129] FIG. 3 diagrammatically shows the sequential steps of a method for using a circumferential ablation device assembly to form a circumferential conduction block in a pulmonary vein. The circumferential ablation method according to FIG. 3 includes: positioning a circumferential ablation element at an ablation region along the pulmonary vein according to a series of detailed steps shown collectively in FIG. 3 as positioning step (3); and thereafter ablating a continuous circumferential region of tissue in the PV wall at the ablation region according to ablation step (4).

[0130] Further to positioning step (3) according to the method of FIG. 3, a distal tip of a guiding catheter is first positioned within the left atrium according to a transeptal access method, which is further described in more detail as follows. The right venous system is first accessed using the “Seldinger” technique, wherein a peripheral vein (such as a femoral vein) is punctured with a needle, the puncture wound is dilated with a dilator to a size sufficient to accommodate an introducer sheath, and an introducer sheath with at least one hemostatic valve is seated within the dilated puncture wound while maintaining relative hemostasis. With the introducer sheath in place, the guiding catheter or sheath is introduced through the hemostatic valve of the introducer sheath and is advanced along the peripheral vein, into the region of the vena cavae, and into the right atrium.

[0131] Once in the right atrium, the distal tip of the guiding catheter is positioned against the fossa ovalis in the intraatrial septal wall. A “Brockenbrough” needle or trocar is then advanced distally through the guide catheter until it punctures the fossa ovalis. A separate dilator may also be advanced with the needle through the fossa ovalis to prepare an access port through the septum for seating the guiding catheter. The guiding catheter thereafter replaces the needle across the septum and is seated in the left atrium through the fossa ovalis, thereby providing access for object devices through its own inner lumen and into the left atrium.

[0132] It is however further contemplated that other left atrial access methods may be suitable substitutes for using a circumferential ablation device assembly for pulmonary vein isolation. In one alternative variation not shown, a “retrograde” approach may be used, wherein the guiding catheter is advanced into the left atrium from the arterial system. In this variation, the Seldinger technique is employed to gain vascular access into the arterial system, rather than the venous, for example, at a femoral artery. The guiding catheter is advanced retrogradedly through the aorta, around the aortic arch, into the ventricle, and then into the left atrium through the mitral valve.

[0133] Subsequent to gaining transeptal access to the left atrium as just described, positioning step (3) according to FIG. 3 next includes advancing a guidewire into a pulmonary vein, which is done generally through the guiding catheter seated in the fossa ovalis. In addition to the left atrial access guiding catheter, the guidewire according to this variation may also be advanced into the pulmonary vein by directing it into the vein with a second sub-selective delivery catheter (not shown) which is coaxial within the guiding catheter, such as, for example, by using one of the directional catheters disclosed in U.S. Pat. No. 5,575,766 to Swartz. Or, the guidewire may have sufficient stiffness and maneuverability in the left atrial cavity to unitarily subselect the desired pulmonary vein distally of the guiding catheter seated at the fossa ovalis.

[0134] Suitable guidewire designs for use in the overall circumferential ablation device assembly described may be selected from previously known designs, while generally any suitable choice should include a shaped, radiopaque distal end portion with a relatively stiff, torquable proximal portion adapted to steer the shaped tip under X-ray visualization. Guidewires having an outer diameter ranging from 0.010″ to 0.035″ may be suitable. In cases where the guidewire is used to bridge the atrium from the guiding catheter at the fossa ovalis, and where no other sub-selective guiding catheters are used, guidewires having an outer diameter ranging from 0.018″ to 0.035″ may be required. It is believed that guidewires within this size range may be required to provide sufficient stiffness and maneuverability in order to allow for guidewire control and to prevent undesirable guidewire prolapsing within the relatively open atrial cavity.

[0135] Subsequent to gaining pulmonary vein access, positioning step (3) of FIG. 3 next includes tracking the distal end portion of a circumferential ablation device assembly over the guidewire and into the pulmonary vein, followed by positioning a circumferential ablation element at an ablation region of the pulmonary vein where the circumferential conduction block is to be desirably formed.

[0136] FIGS. 3-4 further show a circumferential ablation device assembly (100) during use in performing positioning step (3) and ablation step (4) just described with reference to FIG. 3. Included in the circumferential ablation device assembly (100) are guiding, catheter (101), guidewire (102), and circumferential ablation catheter (103).

[0137] More specifically, FIG. 4 shows guiding catheter (101) subsequent to performing a transeptal access method according to FIG. 3, and also shows guidewire (102) subsequent to advancement and positioning within a pulmonary vein, also according to step (3) of FIG. 3. FIG. 4 shows circumferential ablation catheter (103) as it tracks coaxially over guidewire (102) with a distal guidewire tracking member, which is specifically shown only in part at first and second distal guidewire ports (142,144) located on the distal end portion (132) of an elongate catheter body (130). A guidewire lumen (not shown) extends between the first and second distal guidewire ports (142,144) and is adapted to slideably receive and track over the guidewire. In the particular variation of FIG. 4, the second distal guidewire port (142) is located on a distal end portion (132) of the elongate catheter body (130), although proximally of first distal guidewire port (142).

[0138] As would be apparent to one of ordinary skill, the distal guidewire tracking member shown in FIG. 4 and just described may be slideably coupled to the guidewire externally of the body in a “backloading” technique after the guidewire is first positioned in the pulmonary vein. Furthermore, there is no need in this guidewire tracking variation for a guidewire lumen in the proximal portions of the elongate catheter body (130), which allows for a reduction in the outer diameter of the catheter shaft in that region. Nevertheless, it is further contemplated that a design which places the second distal guidewire port on the proximal end portion of the elongate catheter body would also be acceptable, as is described below, for example, with reference to the perfusion embodiment of FIGS. 6A-B.

[0139] In addition, the inclusion of a guidewire lumen extending within the elongate body between first and second ports, as provided in FIG. 4, should not limit the scope of acceptable guidewire tracking members. Other guidewire tracking members which form a bore adapted to slideably receive and track over a guidewire are also considered acceptable, such as, for example, the structure adapted to engage a guidewire as described in U.S. Pat. No. 5,505,702 to Arney, the entirety of which is hereby incorporated by reference herein.

[0140] While the assemblies and methods shown variously throughout the Figures include a guidewire coupled to a guidewire tracking member on the circumferential ablation catheter, other detailed variations may also be suitable for positioning the circumferential ablation element at the ablation region in order to form a circumferential conduction block there. For example, an alternative circumferential ablation catheter not shown may include a “fixed-wire”-type of design wherein a guidewire is integrated into the ablation catheter as one unit. In another alternative assembly, the same type of sub-selective sheaths described above with reference to U.S. Pat. No. 5,575,766 to Swartz for advancing a guidewire into a pulmonary vein may also be used for advancing a circumferential ablation catheter device across the atrium and into a pulmonary vein.

[0141] FIG. 4 also shows circumferential ablation catheter (103) with a circumferential ablation element (160) formed on an expandable member (170). The expandable member (170) is shown in FIG. 4 in a radially collapsed position adapted for percutaneous translumenal delivery into the pulmonary vein according to positioning step (3) of FIG. 3. However, expandable member (170) is also adjustable to a radially expanded position when actuated by an expansion actuator (175), as shown in FIG. 5. Expansion actuator (175) may include, but is not limited to, a pressurizeable fluid source. According to the expanded state shown in FIG. 5, expandable member (170) includes a working length L relative to the longitudinal axis of the elongate catheter body which has a larger expanded outer diameter OD than when in the radially collapsed position. Furthermore, the expanded outer diameter OD is sufficient to circumferentially engage the ablation region of the pulmonary vein. Therefore, the terms “working length” are herein intended to mean the length of an expandable member which, when in a radially expanded position, has an expanded outer diameter that is: (a) greater than the outer diameter of the expandable member when in a radially collapsed position; and (b) sufficient to engage a body space wall or adjacent ablation region surrounding the expandable member, at least on two opposing internal sides of the body space wall or adjacent ablation region, with sufficient surface area to anchor the expandable member.

[0142] Circumferential ablation element (160) also includes a circumferential band (52) on the outer surface of working length L which is coupled to an ablation actuator (190) at a proximal end portion of the elongate catheter body (shown schematically). After expandable member (170) is adjusted to the radially expanded position and at least a portion of working length L circumferentially engages the pulmonary vein wall in the ablation region, the circumferential band (152) of the circumferential ablation element (160) is actuated by ablation actuator (190) to ablate the surrounding circumferential path of tissue in the pulmonary vein wall, thereby forming a circumferential lesion that circumscribes the pulmonary vein lumen and transects the electricale conductivity of the pulmonary vein to block conduction in a direction along its longitudinal axis.

[0143] FIG. 6A shows another circumferential ablation catheter (203) during use also according to the method of FIG. 3, wherein a perfusion lumen (260) (shown in phantom in FIG. 6B) is formed within the distal end portion (232) of elongate catheter body (230). The perfusion lumen (260) in this example is formed between a distal perfusion port, which in this example is the first distal guidewire port (242), and proximal perfusion port (244). Proximal perfusion port (244) is formed through the wall of the elongate catheter body (230) and communicates with the guidewire lumen (not shown) which also forms the perfusion lumen between the distal and proximal perfusion ports. In the particular design shown, after the guidewire has provided for the placement of the ablation element into the pulmonary vein, the guidewire is withdrawn proximally of the proximal perfusion port (244) (shown schematically in shadow) so that the lumen between the ports is clear for antegrade blood flow into the distal perfusion port (242), proximally along the perfusion lumen, out the proximal perfusion port (244) and into the atrium (perfusion flow shown schematically with arrows).

[0144] Further to the perfusion design shown in FIGS. 6A-B, guidewire (102) is positioned in a guidewire lumen which extends the entire length of the elongate catheter body (230) in an “over-the-wire”-type of design, which facilitates the proximal withdrawal of the guidewire to allow for perfusion while maintaining the ability to subsequently re-advance the guidewire distally through the first distal guidewire port (242) for catheter repositioning. In one alternative variation not shown, the guidewire is simply withdrawn and disengaged from the second distal guidewire port (244), in which case the circumferential ablation catheter must generally be withdrawn from the body in order to re-couple the distal guidewire tracking member with the guidewire.

[0145] In another alternative perfusion variation not shown which is a modification of the embodiment of FIG. 6A, a proximal perfusion port is provided as a separate and distinct port positioned between the second distal guidewire port (244) and the expandable member (270), which allows for proximal withdrawal of the guidewire to clear the guidewire lumen and thereby form a perfusion lumen between the first distal guidewire port and the proximal perfusion port. The guidewire of this alternative variation, however, remains engaged within the guidewire lumen between the second distal guidewire port and the proximal perfusion port.

[0146] Passive perfusion during expansion of the expandable member is believed to minimize stasis and allow the target pulmonary vein to continue in its atrial filling function during the atrial arrhythmia treatment procedure. Without this perfusion feature, the expandable member when in the radially expanded position during ablation blocks the flow from the vein into the atrium, which flow stasis may result in undesirable thrombogenesis in the pulmonary vein distally to the expandable member. In addition, in cases where the ablation element is adapted to ablate tissue with heat conduction at the ablation region, as described by reference to more detailed embodiments below, the perfusion feature according to the variation of FIGS. 6A-B may also provide a cooling function in the surrounding region, including in the blood adjacent to the expandable member.

[0147] Moreover, in addition to the specific perfusion structure shown and described by reference to FIGS. 6A-B, it is to be further understood that other structural variants which allow for perfusion flow during expansion of the expandable element may provide suitable substitutes according to one of ordinary skill.

[0148] FIG. 7 shows pulmonary vein (52) after removing the circumferential ablation device assembly subsequent to forming a circumferential lesion (70) around the ablation region of the pulmonary vein wall (53) according to the use of the circumferential ablation device assembly shown in stepwise fashion in FIGS. 3-6. Circumferential lesion (70) is shown located along the pulmonary vein adjacent to the pulmonary vein ostium (54), and is shown to also be “transmural,” which is herein intended to mean extending completely through the wall, from one side to the other. Also, the circumferential lesion (70) is shown in FIG. 7 to form a “continuous” circumferential band, which is herein intended to mean without gaps around the pulmonary vein wall circumference, thereby circumscribing the pulmonary vein lumen.

[0149] It is believed, however, that circumferential catheter ablation with a circumferential ablation element according to various uses of the ultrasound ablation element structures of the present invention may leave some tissue, either transmurally or along the circumference of the lesion, which is not actually ablated, but which is not substantial enough to allow for the passage of conductive signals. Therefore, the terms “transmural” and “continuous” as just defined are intended to have functional limitations, wherein some tissue in the ablation region may be unablated but there are no functional gaps which allow for symptomatically arrhythmogenic signals to conduct through the conduction block and into the atrium from the pulmonary vein.

[0150] Moreover, it is believed that the functionally transmural and continuous lesion qualities just described are characteristic of a completed circumferential conduction block in the pulmonary vein. Such a circumferential conduction block thereby transects the vein, isolating conduction between the portion of the vein on one longitudinal side of the lesion and the portion on the other side. Therefore, any foci of originating arrhythmogenic conduction which is opposite the conduction block from the atrium is prevented by the conduction block from conducting down into the atrium and atrial arrhythmic affects are therefore nullified.

[0151] FIGS. 8A-B show a further circumferential ablation member (350) that includes a radially compliant expandable member (370) which is adapted to conform to a pulmonary vein ostium (54) at least in part by adjusting it to a radially expanded position while in the left atrium and then advancing it into the ostium. FIG. 8A shows expandable member (370) after being adjusted to a radially expanded position while located in the left atrium (50). FIG. 8B further shows expandable member (370) after being advanced into the pulmonary vein (52) until at least a portion of the expanded working length L of circumferential ablation member (350), which includes a circumferential band (352), engages the pulmonary vein ostium (54). FIG. 8C shows a portion of a circumferential lesion (72) which forms a circumferential conduction block in the region of the pulmonary vein ostium (54) subsequent to actuating the circumferential ablation element to form the circumferential lesion.

[0152] In addition to conforming to the pulmonary vein ostium, expandable member (370) is also shown in FIG. 8B to engage a circumferential path of tissue along the left posterior atrial wall which surrounds ostium (54). Moreover, circumferential bank (352) of the circumferential ablation member is also thereby adapted to engage that atrial wall tissue. Therefore, the circumferential conduction block formed according to the method shown and just described in sequential steps by reference to FIGS. 8A-B, as shown in-part in FIG. 8C, includes ablating the circumferential path of atrial wall tissue which surrounds ostium (54). Accordingly, the entire pulmonary vein, including the ostium, is thereby electrically isolated from at least a substantial portion of the left atrial wall which includes the other of the pulmonary vein ostia, as would be apparent to one of ordinary skill according to the sequential method steps shown in FIGS. 8A-B and by further reference to the resulting circumferential lesion (72) shown in FIG. 8C.

[0153] FIGS. 8D-E show another highly beneficial circumferential ablation device embodiment and use thereof for electrically isolating pulmonary vein and ostium from a substantial portion of the left posterior atrial wall. However, unlike the embodiment previously shown and described by reference to FIGS. 8A-C, the FIGS. 8D-E embodiment isolates the pulmonary vein without also ablating tissue along the lumen or lining of the pulmonary vein or ostium, as is apparent by reference to the resulting circumferential conduction block shown in FIG. 8f.

[0154] In more detail, FIG. 8D shows a similar device assembly as that shown in FIGS. 8A/B, except that circumferential band (352′) has a geometry (primarily width) and position along expandable member (370′) such that it is adapted to engage only a circumferential path of tissue along the left posterior atrial wall which surrounds the pulmonary vein ostium. In one aspect of this embodiment, the compliant nature of the expandable member may be self-conforming to the region of the ostium such that the circumferential band is placed against this atrial wall tissue merely by way of conformability.

[0155] In another variation, a “pear”-shaped expandable member or balloon that includes a contoured taper may be suitable for use according to the FIG. 8D embodiment, as is shown by way of example in FIG. 8E. Such a pear shape may be preformed into the expandable member or balloon, or the member may be adapted to form this shape by way of controlled compliance as it expands, such as for example by the use of composite structures within the balloon construction. In any case, according to the “pear”-shaped variation, the circumferential band (352′) of the ablation member is preferably placed along the surface of the contoured taper which is adapted to face the left posterior atrial wall during use according to the method illustrated by FIG. 8D. It is further contemplated that the ablation element may be further extended or alternatively positioned along other portions of the taper, such as is shown by example in shadow at extended band (352″) in FIG. 8E. Accordingly, the variation shown in FIG. 8E to include extended band (352″) may also adapt this particular device embodiment for use in forming circumferential conduction blocks also along tissue within the pulmonary vein and ostium, such as according to the previously described method shown in FIGS. 8A-C.

[0156] The method of forming a circumferential conduction block along a circumferential path of tissue along a left posterior atrial wall and which surrounds a pulmonary vein ostium without ablating the tissue of the vein or ostium should not be limited to the particular device embodiments just illustrated by reference to FIGS. 8D-F. Other device variations may be acceptable substitute for use according to this method. In one particular example which is believed to be suitable, a “looped” ablation member such as the embodiment illustrated below by reference to FIG. 15 may be adapted to form a “looped” ablation element within the left atrium and then be advanced against the left posterior atrial wall such that the loop engages the circumferential path of tissue along the atrial wall and which surrounds a vein ostium. Thereafter, the looped ablation element may be actuated to ablate the engaged tissue, such as for further illustration like a branding iron forming the predetermined pattern around the pulmonary vein os. In addition, other device or method variations may also be suitable substitutes according to one of ordinary skill.

[0157] FIGS. 9A-D collectively show a circumferential ablation device assembly as it is used to form a circumferential conduction block adjunctively to the formation of long linear lesions in a less-invasive “maze”-type procedure, as introduced above for the treatment of multiwavelet reentrant type fibrillation along the left atrial wall.

[0158] More specifically, FIG. 9A diagrammatically shows a summary of steps for performing a “maze”-type procedure by forming circumferential conduction blocks that intersect with long linear conduction blocks formed between the pulmonary veins. As disclosed in copending patent application(Application Number not yet assigned) entitled “Tissue Ablation Device and Method of Use” filed by Michael Lesh, M. D. on May 9, 1997, which is herein incorporated in its entirety by reference thereto, a box-like conduction block surrounding an arrhythmogenic atrial wall region bounded by the pulmonary veins may be created by forming long linear lesions between anchors in all pairs of adjacent pulmonary vein ostia, such as is shown in part in steps (5) and (6) of FIG. 9A. However, it is further believed that, in some particular applications, such linear lesions may be made sufficiently narrow with respect to the surface area of the pulmonary vein ostia that they may not intersect, thereby leaving gaps between them which may present proarrhythmic pathways for abnormal conduction into and from the box, such as is shown between linear lesions (57,58) in FIG. 9B. Therefore, by forming the circumferential conduction block according to step (7) of FIG. 9A, and as shown by use of circumferential ablation member (450) in FIG. 9C, the linear lesions are thereby bridged and the gaps are closed.

[0159] In a further variation to the specific embodiments shown in FIGS. 9B-C, FIG. 9D shows another circumferential ablation device assembly which includes both circumferential and linear ablation elements (452,461), respectively. Circumferential ablation member (450) is shown to include an expandable member (470) which is adjusted to a radially expanded position that is asymmetric to the underlying catheter shaft. Linear ablation member (460) extends along the elongate body proximally from the circumferential ablation member (450). When expanded sufficiently to engage the pulmonary vein wall, expandable member (470) provides at least a portion of an anchor for a first end (462) of linear ablation member (460).

[0160] A shaped stylet (466) is shown in shadow in FIG. 9D within the elongate catheter body in the region of the second end (464) of the linear ablation member (460). Shaped stylet (466) is adapted to push the second end (464) into an adjacent pulmonary vein ostium such that the linear ablation member (460) is adapted to substantially contact the left atrial wall between the adjacent vein ostia to form the linear ablation according to the method of FIG. 9A. In addition to the use of shaped stylet (466), it is further contemplated that a second anchor may be used adjacent to second end (464), such as for example an intermediate guidewire tracking member adapted to track over a guidewire engaged to the pulmonary vein, as shown in FIG. 9E at intermediate guidewire tracking member (466′) which is engaged over guidewire (469).

[0161] In a yet a further variation to the specific embodiment shown in FIG. 9D, FIG. 9E shows a circumferential ablation device assembly which includes both circumferential and linear ablation elements (452,460), respectively. Circumferential ablation member (450) is shown to include an expandable member (470) which is adjusted to a radially expanded position that is asymmetric to the underlying catheter shaft. Linear ablation member (460) extends along the elongate body proximally from the circumferential ablation member (450). When expanded sufficiently to engage the pulmonary vein wall, expandable member (470) provides at least a portion of an anchor for a first end (462) of linear ablation member (460).

[0162] Moreover, the method shown schematically in FIG. 9A and also in various detail by reference to FIGS. 9B-C provides a specific sequence of steps for the purpose of illustration. According to this illustrative sequence, the linear lesions are formed first and then are connected thereafter with the circumferential conduction block. However, a circumferential conduction block may be formed prior to the formation of the linear lesions or conduction blocks, or in any other combination or sub-combination of sequential steps, so long as the resulting combination of lesions allows for the circumferential block to intersect with and connect with the linear lesions. In addition, the circumferential conduction block which connects the linear lesions may also include a circumferential path of tissue which surrounds and electrically isolates the pulmonary vein ostium from the rest of the left posterior atrial wall, such as for example by considering the embodiments just shown and described by reference to FIGS. 9A-E in view of the embodiment previously shown and described in relation to FIG. 8C above.

[0163] In addition to the particular embodiments just shown and described by reference to FIGS. 9A-E, other methods are also contemplated for combining circumferential and linear conduction blocks device assemblies and uses in order to perform a less-invasive “maze”-type procedure. For example, FIG. 9F shows one particular lesion pattern which results by combining a circumferential conduction block, formed according to the previous embodiments of FIGS. 8A-C, with a pair of linear lesions which are formed according to the method illustrated by FIG. 9B. In a further example shown in FIG. 9G, another lesion pattern is formed by combining the pair of linear lesions of FIG. 9B with a circumferential conduction block formed according to the embodiments which are previously illustrated above by reference to FIGS. 9D-F. While the resulting lesion patterns of FIGS. 9F and 9G differ slightly as regards the particular geometry and position of the circumferential conduction block formed, the two variations are also similar in that the circumferential conduction block includes a circumferential path of atrial wall tissue. When such circumferential conduction blocks are formed between adjacent pulmonary vein ostia, shorter linear lesions are therefore sufficient to bridge the circumferential lesions during the overall “maze”-type procedure.

[0164] To this end, according to one contemplated less-invasive “maze”-type procedure (not shown) wherein multiple circumferential conduction blocks are formed in atrial wall tissue such that each pulmonary vein ostium is surrounded by and is electrically isolated with one circumferential conduction block. A series of four linear lesions may be formed between the various pairs of adjacent ostia and with just sufficient length to intersect with and bridge the corresponding adjacent circumferential blocks. A box-like conduction block is thereby formed by the four circumferential conduction blocks and the four bridging linear lesions. A fifth linear lesion may be also formed between at least a portion of the box-like conduction block and another predetermined location, such as for example the mitral value annulus.

[0165] FIG. 9H shows yet a further variation for forming circumferential conduction blocks along atrial wall tissue around the pulmonary vein ostia during a less invasive “maze”-type procedure. According to this further variation, the circumferential conduction block patterns formed around each of two adjacent superior and inferior pulmonary vein ostia are shown in FIG. 9H to intersect, thereby alleviating the need for a linear lesion in order to form a conduction block between the ostia. Furthermore, the distances between the inferior and superior ostia, both on the right and left side of the posterior atrial wall, are believed to be significantly shorter than the distances between the two adjacent superior or inferior ostia. Therefore, FIG. 9H only shows the overlapping circumferential conduction blocks as just described to be positioned vertically between the inferior-superior pairs of adjacent ostia, and further shows linear lesions which are used to connect the right and left sided ostia of the superior and inferior pairs. In some instances these linear lesions will not be required to cure, treat or prevent a particular atrial arrhythmia condition. However, other combinations of these patterns are further contemplated, such as for example using only overlapping circumferential conduction blocks between all adjacent pairs of ostia in order to form the entire “maze”-type left atrial pattern.

[0166] FIG. 10 diagrammatically shows a further method for using a circumferential ablation device assembly wherein electrical signals along the pulmonary vein are monitored with a sensing element before and after ablation according to steps (8) and (9), respectively. Signals within the pulmonary vein are monitored prior to forming a conduction block, as indicated in step (8) in FIG. 10, in order to confirm that the pulmonary vein chosen contains an arrhythmogenic origin for atrial arrhythmia. Failure to confirm an arrhythmogenic origin in the pulmonary vein, particularly in the case of a patient diagnosed with focal arrhythmia, may dictate the need to monitor signals in another pulmonary vein in order to direct treatment to the proper location in the heart. In addition, monitoring the pre-ablation signals may be used to indicate the location of the arrhythmogenic origin of the atrial arrhythmia, which information helps determine the best location to form the conduction block. As such, the conduction block may be positioned to include and therefore ablate the actual focal origin of the arrhythmia, or may be positioned between the focus and the atrium in order to block aberrant conduction from the focal origin and into the atrial wall.

[0167] In addition or in the alternative to monitoring electrical conduction signals in the pulmonary vein prior to ablation, electrical signals along the pulmonary vein wall may also be monitored by the sensing element subsequent to circumferential ablation, according to step (9) of the method of FIG. 10. This monitoring method aids in testing the efficacy of the ablation in forming a complete conduction block against arrhythmogenic conduction. Arrhythmogenic firing from the identified focus will not be observed during signal monitoring along the pulmonary vein wall when taken below a continuous circumferential and transmural lesion formation, and thus would characterize a successful circumferential conduction block. In contrast, observation of such arrhythmogenic signals between the lesion and the atrial wall characterizes a functionally incomplete or discontinuous circumference (gaps) or depth (transmurality) which would potentially identify the need for a subsequent follow-up procedure, such as a second circumferential lesioning procedure in the ablation region.

[0168] A test electrode may also be used in a “post ablation” signal monitoring method according to step (10) of FIG. 10. In one particular embodiment not shown, the test electrode is positioned on the distal end portion of an elongate catheter body and is electrically coupled to a current source for firing a test signal into the tissue surrounding the test electrode when it is placed distally or “upstream” of the circumferential lesion in an attempt to simulate a focal arrhythmia. This test signal generally challenges the robustness of the circumferential lesion in preventing atrial arrhythmia from any such future physiologically generated aberrant activity along the suspect vein.

[0169] Further to the signal monitoring and test stimulus methods just described, such methods may be performed with a separate electrode or electrode pair located on the catheter distal end portion adjacent to the region of the circumferential ablation element, or may be performed using one or more electrodes which form the circumferential ablation element itself, as will be further developed below.

[0170] Circumferential Ablation Member

[0171] The designs for an expandable member and circumferential ablation element for use in a circumferential ablation device assembly have been described generically with reference to the embodiments shown in the previous Figures. Examples of more specific expandable member and ablation element embodiments which are adapted for use in such ablation device assemblies are further provided as follows.

[0172] Notwithstanding their somewhat schematic detail, the circumferential ablation members shown in the previous figures do illustrate one particular embodiment wherein a circumferential electrode element circumscribes an outer surface of an expandable member. The expandable member of the embodiments shown may take one of several different forms, although the expandable member is generally herein shown as an inflatable balloon that is coupled to an expansion actuator (175) which is a pressurizeable fluid source. The balloon is preferably made of a polymeric material and forms a fluid chamber which communicates with a fluid passageway (not shown in the figures) that extends proximally along the elongate catheter body and terminates proximally in a proximal fluid port that is adapted to couple to the pressurizeable fluid source.

[0173] In one expandable balloon variation, the balloon is constructed of a relatively inelastic plastics (e.g., polymers or monomers) such as a polyethylene (“PE”; preferably linear low density or high density or blends thereof), polyolefin copolymer (“POC”), polyethylene terepthalate (“PET”), polyimide, or a nylon material. In this construction, the balloon has a low radial yield or compliance over a working range of pressures and may be folded into a predetermined configuration when deflated in order to facilitate introduction of the balloon into the desired ablation location via known percutaneous catheterization techniques. In this variation, one balloon size may not suitably engage all pulmonary vein walls for performing the circumferential ablation methods herein described on all needy patients. Therefore, it is further contemplated that a kit of multiple ablation catheters, with each balloon working length having a unique predetermined expanded diameter, may be provided from which a treating physician may chose a particular device to meet a particular patient's pulmonary vein anatomy.

[0174] In an alternative expandable balloon variation, the balloon is constructed of a relatively compliant, elastomeric material, such as, for example (but not limited to), a silicone, latex, polyurethane, or mylar elastomer. In this construction, the balloon takes the form of a tubular member in the deflated, non-expanded state. When the elastic tubular balloon is pressurized with fluid such as in the previous, relatively non-compliant example, the material forming the wall of the tubular member elastically deforms and stretches radially to a predetermined diameter for a given inflation pressure. It is further contemplated that the compliant balloon may be constructed as a composite, such as, for example, a latex or silicone balloon skin which includes fibers, such as metal, Kevlar, or nylon fibers, which are embedded into the skin. Such fibers, when provided in a predetermined pattern such as a mesh or braid, may provide a controlled compliance along a preferred axis, preferably limiting longitudinal compliance of the expandable member while allowing for radial compliance.

[0175] It is believed that, among other features, the relatively compliant variation may provide a wide range of working diameters, which may allow for a wide variety of patients, or of vessels within a single patient, to be treated with just one or a few devices. Furthermore, this range of diameters is achievable over a relatively low range of pressures, which is believed to diminish a potentially traumatic vessel response that may otherwise be presented concomitant with higher pressure inflations, particularly when the inflated balloon is oversized to the vessel. In addition, the low-pressure inflation feature of this variation is suitable because the functional requirement of the expandable balloon is merely to engage the ablation element against a circumferential path along the inner lining of the pulmonary vein wall.

[0176] Moreover, a circumferential ablation member is adapted to conform to the geometry of the pulmonary vein ostium, at least in part by providing substantial compliance to the expandable member, as was shown and described previously by reference to FIGS. 8A-B. Further to this conformability to pulmonary vein ostium as provided in the specific design of FIGS. 8A-B, the working length L of expandable member (370) is also shown to include a taper which has a distally reducing outer diameter from a proximal end (372) to a distal end (374). In either a compliant or the non-compliant balloon, such a distally reducing tapered geometry adapts the circumferential ablation element to conform to the funneling geometry of the pulmonary veins in the region of their ostia in order to facilitate the formation of a circumferential conduction block there.

[0177] Further to the circumferential electrode element embodiment as shown variously throughout the previous illustrative Figures, the circumferential electrode element is coupled to an ablation actuator (190). Ablation actuator (190) generally includes a radio-frequency (“RF”) current source (not shown) that is coupled to both the RF electrode element and also a ground patch (195) which is in skin contact with the patient to complete an RF circuit. In addition, ablation actuator (190) preferably includes a monitoring circuit (not shown) and a control circuit (not shown) which together use either the electrical parameters of the RF circuit or tissue parameters such as temperature in a feedback control loop to drive current through the electrode element during ablation. Also, where a plurality of ablation elements or electrodes in one ablation element are used, a switching means may be used to multiplex the RF current source between the various elements or electrodes.

[0178] FIGS. 11 A-D show various patterns of electrically conductive, circumferential electrode bands as electrode ablation elements, each circumscribing an outer surface of the working length of an expandable member. FIGS. 11A-B show circumferential ablation member (550) to include a continuous circumferential electrode band (552) that circumscribes an outer surface of an expandable member (570). FIG. 11B more specifically shows expandable member (570) as a balloon which is fluidly coupled to a pressurizeable fluid source (175), and further shows electrode band (circumferential ablation element) (552) electrically coupled via electrically conductive lead (554) to ablation actuator (190). In addition, a plurality of apertures (572) are shown in the balloon skin wall of expandable member (570) adjacent to electrode band (552). The purpose of these apertures (572) is to provide a positive flow of fluid such as saline or ringers lactate fluid into the tissue surrounding the electrode band (552). Such fluid flow is believed to reduce the temperature rise in the tissue surrounding the electrode element during RF ablation.

[0179] The shapes shown collectively in FIGS. 11A-D allow for a continuous electrode band to circumscribe an expandable member's working length over a range of expanded diameters, a feature which is believed to be particularly useful with a relatively compliant balloon as the expandable member. In the particular embodiments of FIGS. 11A-D, this feature is provided primarily by a secondary shape given to the electrode band relative to the longitudinal axis of the working length of the expandable member. Electrode band (552) is thus shown in FIGS. 11A-B to take the specific secondary shape of a modified step curve. Other shapes than a modified step curve are also suitable, such as the serpentine or sawtooth secondary shapes shown respectively in FIGS. 11C-D. Other shapes in addition to those shown in FIGS. 11A-D and which meet the defined functional requirements are further contemplated.

[0180] In addition, the electrode band provided by the circumferential ablation elements shown in FIGS. 11C-D and also shown schematically in FIGS. 3-6B has a functional band width w relative to the longitudinal axis of the working length which is only required to be sufficiently wide to form a complete conduction block against conduction along the walls of the pulmonary vein in directions parallel to the longitudinal axis. In contrast, the working length L of the respective expandable element is adapted to securely anchor the distal end portion in place such that the ablation element is firmly positioned at a selected region of the pulmonary vein for ablation. Accordingly, the band width w is relatively narrow compared to the working length L of the expandable element, and the electrode band may thus form a relatively narrow equatorial band which has a band width that is less than two-thirds or even one-half of the working length of the expandable element. Additionally, it is to be noted here and elsewhere throughout the specification, that a narrow band may be placed at locations other than the equator of the expandable element, preferably as long as the band is bordered on both sides by a portion of the working length L.

[0181] In another aspect of the narrow equatorial band variation for the circumferential ablation element, the circumferential lesion formed may also be relatively narrow when compared to its own circumference, and may be less than two-thirds or even one-half its own circumference on the expandable element when expanded. In one arrangement which is believed to be suitable for ablating circumferential lesions in the pulmonary veins as conduction blocks, the band width w is less than 1 cm with a circumference on the working length when expanded that is greater than 1.5 cm.

[0182] FIGS. 12A-B show a further variation of a circumferential ablation element which is adapted to maintain a continuous circumferential lesion pattern over a range of expanded diameters and which includes electrode elements that form a relatively narrow equatorial band around the working length of an expandable balloon member. In this variation, a plurality of individual electrode/ablation elements (562) are included in the circumferential ablation element and are positioned in spaced arrangement along an equatorial band which circumscribes an outer surface of the expandable member's working length L.

[0183] The size and spacing between these individual electrode elements (562), when the balloon is expanded, is adapted to form a substantially continuous circumferential lesion in pulmonary vein wall tissue when in intimal contact adjacent thereto, and is further adapted to form such a lesion over a range of band diameters as the working length is adjusted between a variety of radially expanded positions. Each individual electrode element (562) has two opposite ends (563,564), respectively, along a long axis LA and also has a short axis SA, and is positioned such that the long axis LA is at an acute angle relative to the longitudinal axis La of the elongate catheter body and expandable member (560). At least one of the ends (563,564) along the long axis LA overlaps with an end of another adjacent individual electrode element, such that there is a region of overlap along their circumferential aspect, i.e., there is a region of overlap along the circumferential coordinates. The terms “region of overlap along their circumferential coordinate” are herein intended to mean that the two adjacent ends each are positioned along the working length with a circumferential and also a longitudinal coordinate, wherein they share a common circumferential coordinate. In this arrangement, the circumferential compliance along the working length which accompanies radial expansion of the expandable member also moves the individual electrode elements apart along the circumferential axis. However, the spaced, overlapping arrangement described allows the individual ablation elements to maintain a certain degree of their circumferential overlap, or at least remain close enough together, such that a continuous lesion may be formed without gaps between the elements.

[0184] The construction for suitable circumferential electrode elements in the RF variations herein described, such as the various electrode embodiments described with reference to FIGS. 11A-12B, may comprise a metallic material deposited on the outer surface of the working length using conventional techniques, such as by plasma depositing, sputter coating, chemical vapor deposition, other known techniques which are equivalent for this purpose, or otherwise affixing a metallic shaped member onto the outer surface of the expandable member such as through known adhesive bonding techniques. Other RF electrode arrangements are also considered, so long as they form a circumferential conduction block as previously described. For example, a balloon skin may itself be metallized, such as by mixing conductive metal, including but not as limited to gold, platinum, or silver, with a plastic (e.g., polymer) to form a compounded, conductive matrix as the balloon skin.

[0185] Still further to the RF electrode embodiments, another circumferential ablation member variation (not shown) may also include an expandable member, such as an inflatable balloon, that includes a porous skin that is adapted to allow fluid, such as hypertonic saline solution, to pass from an internal chamber defined by the skin and outwardly into surrounding tissues. Such a porous skin may be constructed according to several different methods, such as by forming holes in an otherwise contiguous plastic (e.g., polymeric) material, including mechanically drilling or using laser energy, or the porous skin may simply be an inherently porous membrane. In any case, by electrically coupling the fluid within the porous balloon skin to an RF current source (preferably monopolar), the porous region of the expandable member serves as an RF electrode wherein RF current flows outwardly through the pores via the conductive fluid. In addition, it is further contemplated that a porous outer skin may be provided externally of another, separate expandable member, such as a separate expandable balloon, wherein the conductive fluid is contained in a region between the porous outer skin and the expandable member contained therein. Various other “fluid electrode” designs than those specifically herein described may also be suitable according to one of ordinary skill upon review of this disclosure.

[0186] In the alternative, or in addition to the RF electrode variations just described, the circumferential ablation element may also include other ablative energy sources or sinks, and particularly may include a thermal conductor that circumscribes the outer circumference of the working length of an expandable member. Examples of suitable thermal conductor arrangements include a metallic element which may, for example, be constructed as previously described for the more detailed RF embodiments above. However, in the thermal conductor embodiment such a metallic element would be generally either resistively heated in a closed loop circuit internal to the catheter, or conductively heated by a heat source coupled to the thermal conductor. In the latter case of conductive heating of the thermal conductor with a heat source, the expandable member may be, for example, a plastic (e.g., polymeric) balloon skin which is inflated with a fluid that is heated either by a resistive coil or by bipolar RF current. In any case, it is believed that a thermal conductor on the outer surface of the expandable member is suitable when it is adapted to heat tissue adjacent thereto to a temperature between 40 deg and 80 deg Celsius.

[0187] Further to the thermal conduction variation for the circumferential ablation element, the perfusion balloon embodiment as shown in FIGS. 6A-B may be particularly useful in such a design. It is believed that ablation through increased temperatures, as provided by example above may also enhance coagulation of blood in the pulmonary vein adjacent to the expandable member, which blood would otherwise remain stagnant without such a perfusion feature.

[0188] One further circumferential ablation element design which is believed to be highly useful in performing the ablation methods herein described is shown in FIG. 13 to include a circumferential ablation member(600) with two insulators (602,604) that encapsulate the proximal and distal ends, respectively, of the working length L of an expandable member (610). In the particular embodiment shown, the insulators (602,604) are thermal insulators, such as a thermal insulator comprising a Teflon material. Expandable member (610) is an inflatable balloon which has a balloon skin (612) that is thermally conductive to surrounding tissue when inflated with a heated fluid which may contain a radiopaque agent, saline fluid, ringers lactate, combinations thereof, other known biocompatible fluids having acceptable heat transfer properties for these purposes, further to the thermal conductor embodiments previously described. By providing these spaced insulators, a circumferential ablation element is formed as an equatorial band (603) of uninsulated balloon skin is located between the opposite insulators. In this configuration, the circumferential ablation element is able to conduct heat externally of the balloon skin much more efficiently at the uninsulated equatorial band (603) than at the insulated portions, and thereby is adapted to ablate only a circumferential region of tissue in a pulmonary vein wall which is adjacent to the equatorial band. It is further noted that this embodiment is not limited to an “equatorial” placement of the ablation element. Rather, a circumferential band may be formed anywhere along the working length of the expandable member and circumscribing the longitudinal axis of the expandable member as previously described.

[0189] FIG. 13 further shows use of a radiopaque marker (620) to identify the location of the equatorial band (603) in order to facilitate placement of that band at a selected ablation region of a pulmonary vein via X-ray visualization. Radiopaque marker (620) is opaque under X-ray, and may be constructed, for example, of a radiopaque metal such as gold, platinum, or tungsten, or may comprise a radiopaque plastic (e.g., polymer) such as a metal loaded polymer. FIG. 13 shows radiopaque marker (620) positioned coaxially over an inner tubular member (621) which is included in a coaxial catheter design as would be apparent to one of ordinary skill. Such a radiopaque marker may also be combined with the other embodiments herein shown and described. To note, when the circumferential ablation member which forms an equatorial band includes a metallic electrode element, such electrode may itself be radiopaque and may not require use of a separate marker as just described.

[0190] The thermal insulator embodiment just described by reference to FIG. 13 is illustrative of a broader embodiment, wherein a circumferential ablation member has an ablating surface along the entire working length of an expandable member, but is shielded from releasing ablative energy into surrounding tissues except for along an unshielded or uninsulated equatorial band. As such, the insulator embodiment contemplates other ablation elements, such as the RF embodiments previously described above, which are provided along the entire working length of an expandable member and which are insulated at their ends to selectively ablate tissue only about an uninsulated equatorial band.

[0191] In a further example using the insulator embodiment in combination with a circumferential RF electrode embodiment, a metallized balloon which includes a conductive balloon skin may have an electrical insulator, such as a plastic (e.g., polymeric) coating, at each end of the working length and thereby selectively ablate tissue with electricity flowing through the uninsulated equatorial band. In this and other insulator embodiments, it is further contemplated that the insulators described may be only partial and still provide the equatorial band result. For instance, in the conductive RF electrode balloon case, a partial electrical insulator will allow a substantial component of current to flow through the uninsulated portion due to a “shorting” response to the lower resistance in that region.

[0192] In still a further example of an insulator combined with an RF ablation electrode, a porous membrane comprises the entire balloon skin of an expandable member. By insulating the proximal and distal end portions of the working length of the expandable member, only the pores in the unexposed equatorial band region are allowed to effuse the electrolyte which carries an ablative RF current.

[0193] Further to the expandable member design for use in a circumferential ablation member as herein described, other expandable members than a balloon are also considered suitable. For example, in one expandable cage embodiment shown in FIG. 14, cage (650) comprises coordinating wires (651) and is expandable to engage a desired ablation region in a pulmonary vein.

[0194] The radial expansion of cage (650) is accomplished as follows. Sheath (652) is secured around the wires proximally of cage (650). However, core (653), which may be a metallic mandrel such as stainless steel, extends through sheath (652) and distally within cage (650) wherein it terminates in a distal tip (656). Wires (651) are secured to distal tip (656), for example, by soldering, welding, adhesive bonding, heat shrinking a plastic (e.g., polymeric) member over the wires, or any combination of these methods. Core (653) is slideable within sheath (652), and may, for example, be housed within a tubular lumen (not shown) within sheath (652), the wires being housed between a coaxial space between the tubular lumen and sheath (652). By moving the sheath (652) relative to core (653) and distal tip (656)(shown by arrows in FIG. 14), the cage (650) is collapsible along its longitudinal axis in order to force an outward radial bias (also shown with arrows in FIG. 14) to wires (651) in an organized fashion to formed a working length of cage (650) which is expanded (not shown).

[0195] Further to the particular expandable cage embodiment shown in FIG. 14, a plurality of ablation electrodes (655) is shown, each being positioned on one of wires (651) and being similarly located along the longitudinal axis of the cage (650). The radial bias given to wires (651) during expansion, together with the location of the ablation electrodes (655), serves to position the plurality of ablation electrodes/elements (655) along a circumferential, equatorial band along the expanded working length of cage (650). The wires forming a cage according to this embodiment may also have another predetermined shape when in the radially expanded position. For example, a taper similar to that shown for expandable member (370) in FIGS. 8A-B may be formed by expanding cage (650), wherein the ablation element formed by ablation electrodes (655) may be positioned between the proximal end and the distal end of the taper.

[0196] Further to the construction of the embodiment shown in FIG. 14, wires (651) are preferably metal, and may comprise stainless steel or a superelastic metal alloy, such as an alloy of nickel and titanium, or a combination of both. Regarding the case of nickel and titanium construction for wires (655), a separate electrical conductor may be required in order to actuate ablation electrodes (655) to efficiently emit ablative current into surrounding tissues. In the case where wires (651) are constructed of stainless steel, they may also serve as electrical conductors for ablation electrodes (655). Further to the stainless steel design, the wires (651) may be coated with an electrical insulator to isolate the electrical flow into surrounding tissues at the site of the ablation electrodes (655). Moreover, the ablation electrodes (655) in the stainless steel wire variation may be formed simply by removing electrical insulation in an isolated region to allow for current to flow into tissue only from that exposed region.

[0197] In a further cage embodiment (not shown) to that shown in FIG. 14, a circumferential strip of electrodes may also be secured to the cage (650) such that the strip circumscribes the cage at a predetermined location along the cage's longitudinal axis. By expanding cage (650) as previously described, the strip of electrodes are adapted to take a circumferential shape according to the shape of the expanded cage (650). Such an electrode strip is preferably flexible, such that it may be easily reconfigured when the cage is adjusted between the radially collapsed and expanded positions and such that the strip may be easily advanced and withdrawn with the cage within the delivery sheath. Furthermore, the electrode strip may be a continuous circumferential electrode such as a conductive spring coil, or may be a flexible strip which includes several separate electrodes along its circumferential length. In the latter case, the flexible strip may electrically couple all of the electrodes to a conductive lead that interfaces with a drive circuit, or each electrode may be separately coupled to one or more such conductive leads.

[0198] Another circumferential ablation element adapted for use in a circumferential conduction block assembly of the type herein described is shown in FIG. 15, wherein circumferential ablation member (700) includes a looped member (710) attached, preferably by heat shrinking, to a distal end of a pusher (730). Looped member (710) and pusher (730) are slideably engaged within delivery sheath (750) such that looped member (710) is in a first collapsed position when positioned and radially confined within delivery sheath (750), and expands to a second expanded position when advanced distally from delivery sheath (750).

[0199] Looped member (710) is shown in more detail in FIG. 15 to include a core (712) which is constructed of a superelastic metal alloy such as a nickel-titanium alloy and which has a looped portion with shape memory in the looped configuration. This looped configuration is shown in FIG. 15 to be in a plane which is off-axis, preferably perpendicular, to the longitudinal axis of the pusher (730). This off-axis orientation of the loop is adapted to engage a circumferential path of tissue along a pulmonary vein wall which circumscribes the pulmonary vein lumen when the looped member (710) is delivered from the delivery sheath (750) when the delivery sheath is positioned within the vein lumen parallel to its longitudinal axis. An ablation electrode (714) is also shown in FIG. 15 as a metallic coil which is wrapped around core (712) in its looped portion.

[0200] Pusher (730) is further shown in FIG. 15 to include a tubular pusher member (732) which is heat shrunk over two ends (712′) of core (712) which extend proximally of looped member (710) through pusher (730) in the particular variation shown. While in this embodiment core (712) extends through the pusher in order to provide stiffness to the composite design for the pusher, it is further contemplated that the superelastic metal of the core may be replaced or augmented in the pusher region with another different mandrel or pusher core (not shown), such as a stiffer stainless steel mandrel. Also shown within pusher (730) is an electrically conductive lead (735) which is coupled to the ablation electrode (714) and which is also adapted in a proximal region of the pusher (not shown) to couple to an ablation actuator (190) such as an RF current source (shown schematically).

[0201] FIGS. 16A-19B show various specific embodiments of a broader circumferential ablation device assembly which utilizes an ultrasonic energy source to ablate tissue. The present circumferential ablation device has particular utility in connection with forming a circumferential lesion within or about a pulmonary vein ostium or within the vein itself in order to form a circumferential conductive block. This application of the present ablation device, however, is merely exemplary, and it is understood that those skilled in the art can readily adapt the present ablation device for applications in other body spaces.

[0202] As common to each of the following embodiments, a source of acoustic energy is provided for a delivery device that also includes an anchoring mechanism. In one mode, the anchoring mechanism comprises an expandable member that also positions the acoustic energy source within the body; however, other anchoring and positioning devices may also be used, such as, for example, a basket mechanism. In a more specific form, the acoustic energy source is located within the expandable member and the expandable member is adapted to engage a circumferential path of tissue either about or along a pulmonary vein in the region of its ostium along a left atrial wall. The acoustic energy source in turn is acoustically coupled to the wall of the expandable member and thus to the circumferential region of tissue engaged by the expandable member wall by emitting a circumferential and longitudinally collimated ultrasound signal when actuated by an acoustic energy driver. The use of acoustic energy, and particularly ultrasonic energy, offers the advantage of simultaneously applying a dose of energy sufficient to ablate a relatively large surface area within or near the heart to a desired heating depth without exposing the heart to a large amount of current. For example, a collimated ultrasonic transducer can form a lesion, which has about a 1.5 mm width, about a 2.5 mm diameter lumen, such as a pulmonary vein and of a sufficient depth to form an effective conductive block. It is believed that an effective conductive block can be formed by producing a lesion within the tissue that is transmural or substantially transmural. Depending upon the patient as well as the location within the pulmonary vein ostium, the lesion may have a depth of 1 millimeter to 10 millimeters. It has been observed that the collimated ultrasonic transducer can be powered to provide a lesion having these parameters so as to form an effective conductive block between the pulmonary vein and the posterior wall of the left atrium.

[0203] With specific reference now to the embodiment illustrated in FIGS. 16A through 16D, a circumferential ablation device assembly (800) includes an elongate body (802) with proximal and distal end portions (810,812), an expandable balloon (820) located along the distal end portion (812) of elongate body (802), and a circumferential ultrasound transducer (830) which forms a circumferential ablation member which is acoustically coupled to the expandable balloon (820). In more detail, FIGS. 16A-C variously show elongate body (802) to include guidewire lumen (804), inflation lumen (806), and electrical lead lumen (808). The ablation device, however, can be of a self steering type rather than an over-the-wire type device.

[0204] Each lumen extends between a proximal port (not shown) and a respective distal port, which distal ports are shown as distal guidewire port (805) for guidewire lumen (804), distal inflation port (807) for inflation lumen (806), and distal lead port (809) for electrical lead lumen (808). Although the guidewire, inflation and electrical lead lumens are generally arranged in a side-by-side relationship, the elongate body (802) can be constructed with one or more of these lumens arranged in a coaxial relationship, or in any of a wide variety of configurations that will be readily apparent to one of ordinary skill in the art.

[0205] In addition, the elongate body (802) is also shown in FIGS. 16A and 16C to include an inner member (803) which extends distally beyond distal inflation and lead ports (807,809), through an interior chamber formed by the expandable balloon (820), and distally beyond expandable balloon (820) where the elongate body terminates in a distal tip. The inner member (803) forms the distal region for the guidewire lumen (804) beyond the inflation and lead ports, and also provides a support member for the cylindrical ultrasound transducer (830) and for the distal neck of the expansion balloon, as described in more detail below.

[0206] One more detailed construction for the components of the elongate body (802) which is believed to be suitable for use in transeptal left atrial ablation procedures is as follows. The elongate body (802) itself may have an outer diameter provided within the range of from about 5 French to about 10 French, and more preferable from about 7 French to about 9 French. The guidewire lumen preferably is adapted to slideably receive guidewires ranging from about 0.010 inch to about 0.038 inch in diameter, and preferably is adapted for use with guidewires ranging from about 0.018 inch to about 0.035 inch in diameter. Where a 0.035 inch guidewire is to be used, the guidewire lumen preferably has an inner diameter of 0.040 inch to about 0.042 inch. In addition, the inflation lumen preferably has an inner diameter of about 0.020 inch in order to allow for rapid deflation times, although may vary based upon the viscosity of inflation medium used, length of the lumen, and other dynamic factors relating to fluid flow and pressure.

[0207] In addition to providing the requisite lumens and support members for the ultrasound transducer assembly, the elongate body (802) of the present embodiment must also be adapted to be introduced into the left atrium such that the distal end portion with balloon and transducer may be placed within the pulmonary vein ostium in a percutaneous translumenal procedure, and even more preferably in a transeptal procedure as otherwise herein provided. Therefore, the distal end portion (812) is preferably flexible and adapted to track over and along a guidewire seated within the targeted pulmonary vein. In one further more detailed construction which is believed to be suitable, the proximal end portion is adapted to be at least 30% more stiff than the distal end portion. According to this relationship, the proximal end portion may be suitably adapted to provide push transmission to the distal end portion while the distal end portion is suitably adapted to track through bending anatomy during in vivo delivery of the distal end portion of the device into the desired ablation region.

[0208] Notwithstanding the specific device constructions just described, other delivery mechanisms for delivering the ultrasound ablation member to the desired ablation region are also contemplated. For example, while the FIG. 16A variation is shown as an “over-the-wire” catheter construction, other guidewire tracking designs may be suitable substitutes, such as, for example, catheter devices which are known as “rapid exchange” or “monorail” variations wherein the guidewire is only housed coaxially within a lumen of the catheter in the distal regions of the catheter. In another example, a deflectable tip design may also be a suitable substitute and which is adapted to independently select a desired pulmonary vein and direct the transducer assembly into the desired location for ablation. Further to this latter variation, the guidewire lumen and guidewire of the FIG. 16A variation may be replaced with a “pullwire” lumen and associated fixed pullwire which is adapted to deflect the catheter tip by applying tension along varied stiffness transitions along the catheter's length. Still further to this pullwire variation, acceptable pullwires may have a diameter within the range from about 0.008 inch to about 0.020 inch, and may further include a taper, such as, for example, a tapered outer diameter from about 0.020 inch to about 0.008 inch.

[0209] More specifically regarding expandable balloon (820) as shown in varied detail between FIGS. 16A and 16C, a central region (822) is generally coaxially disposed over the inner member (803) and is bordered at its end neck regions by proximal and distal adaptions (824,826). The proximal adaption (824) is sealed over elongate body (802) proximally of the distal inflation and the electrical lead ports (807,809), and the distal adaption (826) is sealed over inner member (803). According to this arrangement, a fluid tight interior chamber is formed within expandable balloon (820). This interior chamber is fluidly coupled to a pressurizeable fluid source (not shown) via inflation lumen (806). In addition to the inflation lumen (806), electrical lead lumen (808) also communicates with the interior chamber of expandable balloon (820) so that the ultrasound transducer (830), which is positioned within that chamber and over the inner member (803), may be electrically coupled to an ultrasound drive source or actuator, as will be provided in more detail below.

[0210] The expandable balloon (820) may be constructed from a variety of known materials, although the balloon (820) preferably is adapted to conform to the contour of a pulmonary vein ostium. For this purpose, the balloon material can be of the highly compliant variety, such that the material elongates upon application of pressure and takes on the shape of the body lumen or space when filly inflated. Suitable balloon materials include elastomers, such as, for example, but without limitation, Silicone, latex, or low durometer polyurethane (for example, a durometer of about 80A).

[0211] In addition or in the alternative to constructing the balloon of highly compliant material, the balloon (820) can be formed to have a predefined fully inflated shape (i.e., be preshaped) to generally match the anatomic shape of the body lumen in which the balloon is inflated. For instance, as described below in greater detail, the balloon can have a distally tapering shape to generally match the shape of a pulmonary vein ostium, and/or can include a bulbous proximal end to generally match a transition region of the atrium posterior wall adjacent to the pulmonary vein ostium. In this manner, the desired seating within the irregular geometry of a pulmonary vein or vein ostium can be achieved with both compliant and non-compliant balloon variations.

[0212] Notwithstanding the alternatives which may be acceptable as just described, the balloon (820) is preferably constructed to exhibit at least 300% expansion at 3 atmospheres of pressure, and more preferably to exhibit at least 400% expansion at that pressure. The term “expansion” is herein intended to mean the balloon outer diameter after pressurization divided by the balloon inner diameter before pressurization, wherein the balloon inner diameter before pressurization is taken after the balloon is substantially filled with fluid in a taught configuration. In other words, “expansion” is herein intended to relate to change in diameter that is attributable to the material compliance in a stress strain relationship. In one more detailed construction which is believed to be suitable for use in most conduction block procedures in the region of the pulmonary veins, the balloon is adapted to expand under a normal range of pressure such that its outer diameter may be adjusted from a radially collapsed position of about 5 millimeters to a radially expanded position of about 2.5 centimeters (or approximately 500% expansion ratio).

[0213] The ablation member, which is illustrated in FIGS. 16A-D, takes the form of annular ultrasonic transducer (830). In the illustrated embodiment, the annular ultrasonic transducer (830) has a unitary cylindrical shape with a hollow interior (i.e., is tubular shaped); however, the transducer applicator (830) can have a generally annular shape and be formed of a plurality of segments. For instance, the transducer applicator (830) can be formed by a plurality of tube sectors that together form an annular shape. The tube sectors can also be of sufficient arc lengths so as when joined together, the sectors assembly forms a “clover-leaf” shape. This shape is believed to provide overlap in heated regions between adjacent elements. The generally annular shape can also be formed by a plurality of planar transducer segments which are arranged in a polygon shape (e.g., hexagon). In addition, although in the illustrated embodiment the ultrasonic transducer comprises a single transducer element, the transducer applicator can be formed of a multi-element array, as described in greater detail below.

[0214] As is shown in detail in FIG. 16D, cylindrical ultrasound transducer (830) includes a tubular wall (831) which includes three concentric tubular layers. The central layer (832) is a tubular shaped member of a piezoceramic or piezoelectric crystalline material. The transducer preferably is made of type PZT-4, PZT-5 or PZT-8, quartz or Lithium-Niobate type piezoceramic material to ensure high power output capabilities. These types of transducer materials are commercially available from Stavely Sensors, Inc. of East Hartford, Conn., or from Valpey-Fischer Corp. of Hopkinton, Mass.

[0215] The outer and inner tubular members (833,834) enclose central layer (832) within their coaxial space and are constructed of an electrically conductive material. In the illustrated embodiment, these transducer electrodes (833, 834) comprise a metallic coating, and more preferably a coating of nickel, copper, silver, gold, platinum, or alloys of these metals.

[0216] One more detailed construction for a cylindrical ultrasound transducer for use in the present application is as follows. The length of the transducer (830) or transducer assembly (e.g., multi-element array of transducer elements) desirably is selected for a given clinical application. In connection with forming circumferential condition blocks in cardiac or pulmonary vein wall tissue, the transducer length can fall within the range of approximately 2 mm up to greater than 10 mm, and preferably equals about 5 mm to 10 mm. A transducer accordingly sized is believed to form a lesion of a width sufficient to ensure the integrity of the formed conductive block without undue tissue ablation. For other applications, however, the length can be significantly longer.

[0217] Likewise, the transducer outer diameter desirably is selected to account for delivery through a particular access path (e.g., percutaneously and transeptally), for proper placement and location within a particular body space, and for achieving a desired ablation effect. In the given application within or proximate of the pulmonary vein ostium, the transducer (830) preferably has an outer diameter within the range of about 1.8 mm to greater than 2.5 mm. It has been observed that a transducer with an outer diameter of about 2 mm generates acoustic power levels approaching 20 Watts per centimeter radiator or greater within myocardial or vascular tissue, which is believed to be sufficient for ablation of tissue engaged by the outer balloon for up to about 2 cm outer diameter of the balloon. For applications in other body spaces, the transducer applicator (830) may have an outer diameter within the range of about 1 mm to greater than 3-4 mm (e.g., as large as 1 to 2 cm for applications in some body spaces).

[0218] The central layer (832) of the transducer (830) has a thickness selected to produce a desired operating frequency. The operating frequency will vary of course depending upon clinical needs, such as the tolerable outer diameter of the ablation and the depth of heating, as well as upon the size of the transducer as limited by the delivery path and the size of the target site. As described in greater detail below, the transducer (830) in the illustrated application preferably operates within the range of about 5 MHz to about 20 MHz, and more preferably within the range of about 7 MHz to about 10 MHz. Thus, for example, the transducer can have a thickness of approximately 0.3 mm for an operating frequency of about 7 MHz (i.e., a thickness generally equal to ½ the wavelength associated with the desired operating frequency).

[0219] The transducer (830) is vibrated across the wall thickness and to radiate collimated acoustic energy in the radial direction. For this purpose, as best seen in FIGS. 16A and 16D, the distal ends of electrical leads (836,837) are electrically coupled to outer and inner tubular members or electrodes (833,834), respectively, of the transducer (830), such as, for example, by soldering the leads to the metallic coatings or by resistance welding. In the illustrated embodiment, the electrical leads are 4-8 mil (0.004 to 0.008 inch diameter) silver wire or the like.

[0220] The proximal ends of these leads are adapted to couple to an ultrasonic driver or actuator (840), which is schematically illustrated in FIG. 16D. FIGS. 16A-D further show leads (836,837) as separate wires within electrical lead lumen (808), in which configuration the leads must be well insulated when in close contact. Other configurations for leads (836,837) are therefore contemplated. For example, a coaxial cable may provide one cable for both leads which is well insulated as to inductance interference. Or, the leads may be communicated toward the distal end portion (812) of the elongate body through different lumens which are separated by the catheter body.

[0221] The transducer also can be sectored by scoring or notching the outer transducer electrode (833) and part of the central layer (832) along lines parallel to the longitudinal axis L of the transducer (830), as illustrated in FIG. 16E. A separate electrical lead connects to each sector in order to couple the sector to a dedicated power control that individually excites the corresponding transducer sector. By controlling the driving power and operating frequency to each individual sector, the ultrasonic driver (840) can enhance the uniformity of the ultrasonic beam around the transducer (830), as well as can vary the degree of heating (i.e., lesion control) in the angular dimension.

[0222] The ultrasound transducer just described is combined with the overall device assembly according to the present embodiment as follows. In assembly, the transducer (830) desirably is “air-backed” to produce more energy and to enhance energy distribution uniformity, as known in the art. In other words, the inner member (803) does not contact an appreciable amount of the inner surface of transducer inner tubular member (834). This is because the piezoelectric crystal which forms central layer (832) of ultrasound transducer (830) is adapted to radially contract and expand (or radially “vibrate”) when an alternating current is applied from a current source and across the outer and inner tubular electrodes (833,834) of the crystal via the electrical leads (836,837). This controlled vibration emits the ultrasonic energy which is adapted to ablate tissue and form a circumferential conduction block according to the present embodiment. Therefore, it is believed that appreciable levels of contact along the surface of the crystal may provide a dampening effect which would diminish the vibration of the crystal and thus limit the efficiency of ultrasound transmission.

[0223] For this purpose, the transducer (830) seats coaxial about the inner member (803) and is supported about the inner member (803) in a manner providing a gap between the inner member (803) and the transducer inner tubular member (834). That is, the inner tubular member (834) forms an interior bore (835) which loosely receives the inner member (803). Any of a variety of structures can be used to support the transducer (830) about the inner member (803). For instance, spacers or splines can be used to coaxially position the transducer (830) about the inner member (803) while leaving a generally annular space between these components. In the alternative, other conventional and known approaches to support the transducer can also be used. For instance, O-rings that circumscribe the inner member (803) and lie between the inner member (803) and the transducer (830) can support the transducer (830) in a manner similar to that illustrated in U.S. Pat. Nos. 5,606,974; 5,620,479; and 5,606,974, the disclosures of which were previously incorporated by reference above.

[0224] In the illustrated embodiment, a stand-off (838) is provided in order to ensure that the transducer (830) has a radial separation from the inner member (803) to form a gap filled with air and/or other fluid. In one preferred mode shown in FIG. 16C, stand-off (838) is a tubular member with a plurality of circumferentially spaced outer splines (839) which hold the majority of the transducer inner surface away from the surface of the stand-off between the splines, thereby minimizing dampening affects from the coupling of the transducer to the catheter. The tubular member which forms a stand-off such as stand-off (838) in the FIG. 16D embodiment may also provide its inner bore as the guidewire lumen in the region of the ultrasound transducer, in the alternative to providing a separate stand-off coaxially over another tubular member which forms the inner member, such as according to the FIG. 16D embodiment.

[0225] In a further mode, the elongate body (802) can also include additional lumens which lie either side by side to or coaxial with the guidewire lumen (804) and which terminate at ports located within the space between the inner member (803) and the transducer (830). A cooling medium can circulate through space defined by the stand-off (838) between the inner member (803) and the transducer (830) via these additional lumens. By way of example, carbon dioxide gas, circulated at a rate of 5 liters per minute, can be used as a suitable cooling medium to maintain the transducer at a lower operating temperature. It is believed that such thermal cooling would allow more acoustic power to transmit to the targeted tissue without degradation of the transducer material.

[0226] The transducer (830) desirably is electrically and mechanically isolated from the interior of the balloon (820). Again, any of a variety of coatings, sheaths, sealants, tubings and the like may be suitable for this purpose, such as those described in U.S. Pat. Nos. 5,620,479 and 5,606,974. In the illustrated embodiment, as best illustrated in FIG. 16C, a conventional, flexible, acoustically compatible, and medical grade epoxy (842) is applied over the transducer (830). The epoxy (842) may be, for example, Epotek 301, Epotek 310, which is available commercially from Epoxy Technology, or Tracon FDA-8. In addition, a conventional sealant, such as, for example, General Electric Silicon II gasket glue and sealant, desirably is applied at the proximal and distal ends of the transducer (830) around the exposed portions of the inner member (803), wires (836, 837) and stand-off (838) to seal the space between the transducer (830) and the inner member (803) at these locations.

[0227] An ultra thin-walled polyester heat shrink tubing (844) or the like then seals the epoxy coated transducer. Alternatively, the epoxy covered transducer (830), inner member (803) and stand-off (838) can be instead inserted into a tight thin wall rubber or plastic tubing made from a material such as Teflon®, polyethylene, polyurethane, silastic or the like. The tubing desirably has a thickness of 0.0005 to 0.003 inches.

[0228] When assembling the ablation device assembly, additional epoxy is injected into the tubing after the tubing is placed over the epoxy coated transducer (830). As the tube shrinks, excess epoxy flows out and a thin layer of epoxy remains between the transducer and the heat shrink tubing (844). These layers (842, 844) protect the transducer surface, help acoustically match the transducer (830) to the load, makes the ablation device more robust, and ensures air-tight integrity of the air backing.

[0229] Although not illustrated in FIG. 16A in order to simplify the drawing, the tubing (844) extends beyond the ends of transducer (830) and surrounds a portion of the inner member (803) on either side of the transducer (830). A filler (not shown) can also be used to support the ends of the tubing (844). Suitable fillers include flexible materials such as, for example, but without limitation, epoxy, Teflon® tape and the like.

[0230] The ultrasonic actuator (840) generates alternating current to power the transducer (830). The ultrasonic actuator (840) drives the transducer (830) at frequencies within the range of about 5 to about 20 MHz, and preferably for the illustrated application within the range of about 7 MHz to about 10 MHz. In addition, the ultrasonic driver can modulate the driving frequencies and/or vary power in order to smooth or unify the produced collimated ultrasonic beam. For instance, the function generator of the ultrasonic actuator (840) can drive the transducer at frequencies within the range of 6.8 MHz and 7.2 MHz by continuously or discretely sweeping between these frequencies.

[0231] The ultrasound transducer (830) of the present embodiment sonically couples with the outer skin of the balloon (820) in a manner which forms a circumferential conduction block in a pulmonary vein as follows. Initially, the ultrasound transducer is believed to emit its energy in a circumferential pattern which is highly collimated along the transducer's length relative to its longitudinal axis L (see FIG. 16D). The circumferential band therefore maintains its width and circumferential pattern over an appreciable range of diameters away from the source at the transducer. Also, the balloon is preferably inflated with fluid which is relatively ultrasonically transparent, such as, for example, degassed water. Therefore, by actuating the transducer (830) while the balloon (820) is inflated, the circumferential band of energy is allowed to translate through the inflation fluid and ultimately sonically couple with a circumferential band of balloon skin which circumscribes the balloon (820). Moreover, the circumferential band of balloon skin material may also be further engaged along a circumferential path of tissue which circumscribes the balloon, such as, for example, if the balloon is inflated within and engages a pulmonary vein wall, ostium, or region of atrial wall. Accordingly, where the balloon is constructed of a relatively ultrasonically transparent material, the circumferential band of ultrasound energy is allowed to pass through the balloon skin and into the engaged circumferential path of tissue such that the circumferential path of tissue is ablated.

[0232] Further to the transducer-balloon relationship just described, the energy is coupled to the tissue largely via the inflation fluid and balloon skin. It is believed that, for in vivo uses, the efficiency of energy coupling to the tissue, and therefore ablation efficiency, may significantly diminish in circumstances where there is poor contact and conforming interface between the balloon skin and the tissue. Accordingly, it is contemplated that several different balloon types may be provided for ablating different tissue structures so that a particular shape may be chosen for a particular region of tissue to be ablated.

[0233] In one particular balloon-transducer combination shown in FIG. 16A and also in FIG. 18A, the ultrasound transducer preferably has a length such that the ultrasonically coupled band of the balloon skin, having a similar length d according to the collimated ultrasound signal, is shorter than the working length D of the balloon. According to this aspect of the relationship, the transducer is adapted as a circumferential ablation member which is coupled to the balloon to form an ablation element along a circumferential band of the balloon, therefore forming a circumferential ablation element band which circumscribes the balloon. Preferably, the transducer has a length which is less than two-thirds the working length of the balloon, and more preferably is less than one-half the working length of the balloon. By sizing the ultrasonic transducer length d smaller than the working length D of the balloon (820)—and hence shorter than a longitudinal length of the engagement area between the balloon (820) and the wall of the body space (e.g., pulmonary vein ostium)—and by generally centering the transducer (830) within the balloon's working length D, the transducer (830) operates in a field isolated from the blood pool. A generally equatorial position of the transducer (830) relative to the ends of the balloon's working length also assists in the isolation of the transducer (830) from the blood pool.

[0234] It is believed that the transducer placement according to this arrangement may be preventative of thrombus formation which might otherwise occur at a lesion sight, particularly in the left atrium.

[0235] The ultrasound transducer described in various levels of detail above has been observed to provide a suitable degree of radiopacity for locating the energy source at a desired location for ablating the conductive block. However, it is further contemplated that the elongate body (802) may include an additional radiopaque marker or markers (not shown) to identify the location of the ultrasonic transducer (830) in order to facilitate placement of the transducer at a selected ablation region of a pulmonary vein via X-ray visualization. The radiopaque marker is opaque under X-ray, and can be constructed, for example, of a radiopaque metal such as gold, platinum, or tungsten, or can comprise a radiopaque plastic (e.g., polymer) such as a metal loaded polymer. The radiopaque marker is positioned coaxially over an inner tubular member (803), in a manner similar to that described in connection with the embodiment of FIG. 13.

[0236] The present circumferential ablation device is introduced into a pulmonary vein of the left atrium in a manner similar to that described above. Once properly positioned within the pulmonary vein or vein ostium, the pressurized fluid source inflates the balloon (820) to engage the lumenal surface of the pulmonary vein ostium. Once properly positioned, the ultrasonic driver (840) is energized to drive the transducer (830). It is believed that by driving the ultrasonic transducer 830 at 20 acoustical watts at an operating frequency of 7 megahertz, that a sufficiently sized lesion can be formed circumferentially about the pulmonary vein ostium in a relatively short period of time (e.g., 1 to 2 minutes or less). It is also contemplated that the control level of energy can be delivered, then tested for lesion formation with a test stimulus in the pulmonary vein, either from an electrode provided at the tip area of the ultrasonic catheter or on a separate device such as a guidewire through the ultrasonic catheter. Therefore, the procedure may involve ablation at a first energy level in time, then check for the effective conductive block provided by the resulting lesion, and then subsequent ablations and testing until a complete conductive block is formed. In the alternative, the circumferential ablation device may also include feedback control, for example, if thermocouples are provided at the circumferential element formed along the balloon outer surface. Monitoring temperature at this location provides indicia for the progression of the lesion. This feedback feature may be used in addition to or in the alternative to the multi-step procedure described above.

[0237] FIGS. 17A-C show various alternative designs for the purpose of illustrating the relationship between the ultrasound transducer and balloon of the assemblies just described above. More specifically, FIG. 17A shows the balloon (820) having “straight” configuration with a working length L and a relatively constant diameter X between proximal and distal tapers (824, 826). As is shown in FIG. 17A, this variation is believed to be particularly well adapted for use in forming a circumferential conduction block along a circumferential path of tissue which circumscribes and transects a pulmonary vein wall. However, unless the balloon is constructed of a material having a high degree of compliance and conformability, this shape may provide for gaps in contact between the desired circumferential band of tissue and the circumferential band of the balloon skin along the working length of the balloon (820).

[0238] The balloon (820) in FIG. 17A is also concentrically positioned relative to the longitudinal axis of the elongate body (802). It is understood, however, that the balloon can be asymmetrically positioned on the elongate body, and that the ablation device can include more than one balloon.

[0239] FIG. 17B shows another circumferential ablation device assembly for pulmonary vein isolation, although this assembly includes a balloon (820) which has a tapered outer diameter from a proximal outer diameter X₂to a smaller distal outer diameter X₁. (Like reference numerals have been used in each of these embodiments in order to identify generally common elements between the embodiments.) According to this mode, this tapered shape is believed to conform well to other tapering regions of space, and may also be particularly beneficial for use in engaging and ablating circumferential paths of tissue along a pulmonary vein ostium.

[0240] FIG. 17C further shows a similar shape for the balloon as that just illustrated by reference to FIG. 17B, except that the FIG. 17C embodiment further includes a balloon (820) and includes a bulbous proximal end (846). In the illustrated embodiment, the proximate bulbous end (846) of the central region (822) gives the balloon (820) a “pear”-shape. More specifically, a contoured surface (848) is positioned along the tapered working length L and between proximal shoulder (824) and the smaller distal shoulder (826) of balloon (820). As is suggested by view of FIG. 17C, this pear shaped embodiment is believed to be beneficial for forming the circumferential conduction block along a circumferential path of atrial wall tissue which surrounds and perhaps includes the pulmonary vein ostium. For example, the device shown in FIG. 17C is believed to be suited to form a similar lesion to that shown at circumferential lesion (850) in FIG. 17D. Circumferential lesion (850) electrically isolates the respective pulmonary vein (852) from a substantial portion of the left atrial wall. The device shown in FIG. 17C is also believed to be suited to form an elongate lesion which extends along a substantial portion of the pulmonary vein ostium (854), e.g., between the proximal edge of the illustrated lesion (850) and the dashed line (856) which schematically marks a distal edge of such an exemplary elongate lesion (850).

[0241] As mentioned above, the transducer (830) can be formed of an array of multiple transducer elements that are arranged in series and coaxial. The transducer can also be formed to have a plurality of longitudinal sectors. These modes of the transducer have particular utility in connection with the tapering balloon designs illustrated in FIGS. 17B and 17C. In these cases, because of the differing distances along the length of the transducer between the transducer and the targeted tissue, it is believed that a non-uniform heating depth could occur if the transducer were driven at a constant power. In order to uniformly heat the targeted tissue along the length of the transducer assembly, more power may therefore be required at the proximal end than at the distal end because power falls off as 1/radius from a source (i.e., from the transducer) in water. Moreover, if the transducer (830) is operating in an attenuating fluid, then the desired power level may need to account for the attenuation caused by the fluid. The region of smaller balloon diameter near the distal end thus requires less transducer power output than the region of larger balloon diameter near the proximal end. Further to this premise, in a more specific embodiment transducer elements or sectors, which are individually powered, can be provided and produce a tapering ultrasound power deposition. That is, the proximal transducer element or sector can be driven at a higher power level than the distal transducer element or sector so as to enhance the uniformity of heating when the transducer lies skewed relative to the target site.

[0242] The circumferential ablation device (800) can also include additional mechanisms to control the depth of heating. For instance, the elongate body (802) can include an additional lumen which is arranged on the body so as to circulate the inflation fluid through a closed system. A heat exchanger can remove heat from the inflation fluid and the flow rate through the closed system can be controlled to regulate the temperature of the inflation fluid. The cooled inflation fluid within the balloon (820) can thus act as a heat sink to conduct away some of the heat from the targeted tissue and maintain the tissue below a desired temperature (e.g., 90 decrees C.), and thereby increase the depth of heating. That is, by maintaining the temperature of the tissue at the balloon/tissue interface below a desired temperature, more power can be deposited in the tissue for greater penetration. Conversely, the fluid can be allowed to warm. This use of this feature and the temperature of the inflation fluid can be varied from procedure to procedure, as well as during a particular procedure, in order to tailor the degree of ablation to a given application or patient.

[0243] The depth of heating can also be controlled by selecting the inflation material to have certain absorption characteristics. For example, by selecting an inflation material with higher absorption than water, less energy will reach the balloon wall, thereby limiting thermal penetration into the tissue. It is believed that the following fluids may be suitable for this application: vegetable oil, silicone oil and the like.

[0244] Uniform heating can also be enhanced by rotating the transducer within the balloon. For this purpose, the transducer (830) may be mounted on a torquable member which is movably engaged within a lumen that is formed by the elongate body (802).

[0245] Another aspect of the balloon-transducer relationship of the present embodiment is also illustrated by reference to FIGS. 18A-B. In general as to the variations embodied by those figures, the circumferential ultrasound energy signal is modified at the balloon coupling level such that a third order of control is provided for the tissue lesion pattern (the first order of control is the transducer properties affecting signal emission, such as length, width, shape of the transducer crystal; the second order of control for tissue lesion pattern is the balloon shape, per above by reference to FIGS. 17A-C).

[0246] More particularly, FIG. 18A shows balloon (820) to include a filter (860) which has a predetermined pattern along the balloon surface and which is adapted to shield tissue from the ultrasound signal, for example, by either absorbing or reflecting the ultrasound signal. In the particular variation shown in FIG. 18A, the filter (860) is patterned so that the energy band which is passed through the balloon wall is substantially more narrow than the band which emits from the transducer (830) internally of the balloon (820). The filter (860) can be constructed, for example, by coating the balloon (820) with an ultrasonically reflective material, such as with a metal, or with an ultrasonically absorbent material, such as with a polyurethane elastomer. Or, the filter (860) can be formed by varying the balloon's wall thickness such that a circumferential band (862), which is narrow in the longitudinal direction as compared to the length of the balloon, is also thinner (in a radial direction) than the surrounding regions, thereby preferentially allowing signals to pass through the band (862). The thicker walls of the balloon (820) on either side of the band (862) inhibit propagation of the ultrasonic energy through the balloon skin at these locations.

[0247] For various reasons, the “narrow pass filter” embodiment of FIG. 19A may be particularly well suited for use in forming circumferential conduction blocks in left atrial wall and pulmonary vein tissues. It is believed that the efficiency of ultrasound transmission from a piezoelectric transducer is limited by the length of the transducer, which limitations are further believed to be a function of the wavelength of the emitted signal. Thus, for some applications a transducer (830) may be required to be longer than the length which is desired for the lesion to be formed. Many procedures intending to form conduction blocks in the left atrium or pulmonary veins, such as, for example, less-invasive “maze”-type procedures, require only enough lesion width to create a functional electrical block and to electrically isolate a tissue region. In addition, limiting the amount of damage formed along an atrial wall, even in a controlled ablation procedure, pervades as a general concern. However, a transducer that is necessary to form that block, or which may be desirable for other reasons, may require a length which is much longer and may create lesions which are much wider than is functionally required for the block. A “narrow pass” filter along the balloon provides one solution to such competing interests.

[0248] FIG. 18B shows another variation of the balloon-transducer relationship in an ultrasound ablation assembly. Unlike the variation shown in FIG. 19A, FIG. 18B shows placement of an ultrasonically absorbent band (864) along balloon (820) and directly in the central region of the emitted energy signal from transducer (830). According to this variation, the ultrasonically absorbent band (864) is adapted to heat to a significant temperature rise when sonically coupled to the transducer via the ultrasound signal. It is believed that some ablation methods may benefit from combining ultrasound/thermal conduction modes of ablation in a targeted circumferential band of tissue. In another aspect of this variation, ultrasonically absorbent band (864) may operate as an energy sink as an aid to control the extent of ablation to a less traumatic and invasive level than would be reached by allowing the raw ultrasound energy to couple directly to the tissue. In other words, by heating the absorbent band (864) the signal is diminished to a level that might have a more controlled depth of tissue ablation. Further to this aspect, absorbent band (864) may therefore also have a width which is more commensurate with the length of the transducer, as is shown in an alternative mode in shadow at absorbent band (864).

[0249] In each of the embodiments illustrated in FIGS. 16A through 18B, the ultrasonic transducer had an annular shape so as to emit ultrasonic energy around the entire circumference of the balloon. The present circumferential ablation device, however, can emit a collimated beam of ultrasonic energy in a specific angular exposure. For instance, as seen in FIG. 19A, the transducer can be configured to have only a single active sector (e.g., 180 degree exposure). The transducer can also have a planar shape. By rotating the elongate body (802), the transducer (830) can be swept through 360 degrees in order to form a circumferential ablation. For this purpose, the transducer (830) may be mounted on a torquable member (803), in the manner described above.

[0250] FIG. 19B illustrates another type of ultrasonic transducer which can be mounted to a torquable member (803) within the balloon (820). The transducer (830) is formed by curvilinear section and is mounted on the inner member (803) with its concave surface facing in a radially outward direction. The inner member (803) desirably is formed with recess that substantially matches a portion of the concave surface of the transducer (830). The inner member (803) also includes longitudinal ridges on the edges of the recess that support the transducer above the inner member such that an air gap is formed between the transducer and the inner member. In this manner, the transducer is “air-backed.” This spaced is sealed and closed in the manner described above in connection with the embodiment of FIGS. 16A-E.

[0251] The inverted transducer section produces a highly directional beam pattern. By sweeping the transducer through 360 degrees of rotation, as described above, a circumferential lesion can be formed while using less power than would be required with a planar or tubular transducer.

[0252] Further catheter constructions and associated methods of manufacture are provided in accordance with the present disclosure for mounting an ultrasound transducer, as described in FIGS. 16A-E, onto a catheter shaft. Each of the following transducer mounting constructions can be used with overall catheter construction described above. Accordingly, the following descriptions of an isolated ultrasound transducer mounted on an inner section of a catheter shaft will be understood to be in the context of the catheter assembly, including an associated anchoring device (e.g., a balloon), described above.

[0253] In the variations described below, the transducer is suspended about an inner member (e.g., the catheter shaft) absent any support structure which is sandwiched between or otherwise bridges between the inner member and the transducer along the length of the transducer. That is, transducer mounting is accomplished without the use of internal mounting members and/or elastic member bridging radially between the inner member and the transducer. The mounting arrangements of FIGS. 20A through 25B support the transducer and are attached to the inner member (or to an assembly of members) at points proximal and distal of the ultrasound transducer.

[0254] These designs also capture air within the mounting structures to air back the transducer. That is, the disclosed modes of suspension illustrated in FIGS. 20A through 25B maintain an air gap between the transducer and the catheter shaft. As mentioned above, air backing of a cylindrical acoustic transducer is desirably to ensure maximum radially outward propagation of the ultrasound waves. While the transducer is damped whenever it is in contact with any sort of mounting means between the back or inner side of the transducer and the catheter shaft, even highly elastomeric ones, the disclosed designs of these Figures are constructed to minimize such damping. In addition, the air space desirably is sealed to prevent fluid infiltration, be it blood or water. These features are common to the following construction variations.

[0255] In each of the variations disclosed below, the transducer is constructed for used in applications involving forming a circumferential lesion at a base of or in a pulmonary vein to treat atrial fibrillation as described above. In this application, the transducer preferably is driven in a range of about 6 to about 12 MHz. The transducer for this purpose can have a thickness in the range of about 0.009 (0.23 mm) to about 0.013 inches (0.33 mm). For example, a preferred transducer in accordance with the suspended coaxial transducer embodiment may have an inner diameter of 0.070 inch (1.8 mm) and an outer diameter of 0.096 inch (2.4 mm); thus, having a thickness of 0.013 inch (0.3 mm).

[0256] While the catheter assemblies and associated methods of manufacture disclosed for constructing a suspended, generally coaxial ultrasonic transducer have applications in connection with forming circumferential lesions to treat atrial fibrillation as described above, those skilled in the art will readily recognized that the present constructions and methods of manufacture can be used for constructing ultrasonic elements for the delivery into and the ablation of other body spaces in the treatment of other medical conditions, as well as in connection with other applications outside the medical field. For instance, the ultrasound ablation device described above and the variations thereof described below may be used for joining adjacent linear lesions in a less-invasive “maze”-type procedure, or be used within the coronary sinus to ablate the atrioventricular (AV) node to treat Wolff-Parkinson-White syndrome and any other accessory conductive pathway abnormality. In this latter application, it may be desirably to ablate only a portion of the circumference of the coronary sinus, and as such, the ultrasonic ablation devices illustrated in FIGS. 19A and 19B may find particular applicability. In addition, these types of ablation devices can be mounted onto a pre-shaped catheter shaft that has a curvature that generally matches a natural curvature of the coronary sinus about the exterior of the heart. Such pre-shaped catheter may self-orient within the coronary sinus to position the active ultrasonic transducer toward the inner side of the coronary sinus (i.e., toward the interior of the heart) so as to direct transmission toward the AV node. A catheter constructed with the ultrasonic transducer mounting assemblies disclosed herein can also be designed without an anchoring balloon for use on an end of a flexible catheter for the treatment of ventricular tachycardia.

[0257] With reference to FIGS. 20A and 20B, an external layer coupled to the transducer with a coupling adhesive is described below. By suspending the transducer from such an external protective layer, the problem of maintaining a minimally damped internal mounting scheme is resolved.

[0258] As understood from FIGS. 20A and 20B, a guide member tracking member (900) has a central guide member lumen (902) for slideably engaging and tracking over a guide member (e.g., a guidewire or a steerable catheter). The transducer (904) is generally coaxially disposed over the tracking member (900); however, it is understood that the transducer (904) can be asymmetrically positioned relative to an axis of the guide member tracking member (900) provided an air gap exists between the transducer inner surface and the tracking member (900). An air space (906) exists between the transducer (904) and the tracking member (900), thereby providing an air-backing to maximize the outward radiation of the ultrasonic energy, as described above. It is understood that the transducer need not be mounted on a portion of the catheter that tracks over a guide member, but rather can be mounted on a distal end of a steerable catheter or can be arranged in a side-by-side relationship with such guide member.

[0259] The transducer (904) is held suspended over the tracking member (900) by the cooperative arrangement of an outer cover (910), for example, a shrink-wrap polymeric material (e.g., PET), and end plugs (912) bonded to a length of the tracking member (900) proximal and distal to the transducer (904). In the embodiment illustrated in FIGS. 20A & B, the end plugs (912) are formed of adhesive and lie under the cover (910), and a layer of adhesive (908) covers the transducer (904) and couples the transducer (904) to an inner surface of the outer cover (910).

[0260] The proper air gap may be ensured during setting of the adhesive end plugs (912) by inserting three or more beading mandrels between the tracking member and the transducer. These mandrels would preferable be evenly distributed radially about the tracking member (900) and would run axially along the length of the transducer (910). The beading mandrels can be sized so as to create a desired air gap (e.g., 0.005 inches (0.13 mm)). Since the mandrels must be removed, it is preferred that the beading mandrels be made out of a material to which the epoxy adhesive will not stick, such as for example, metal or silicone, and extend beyond one end of the transducer (904) during the assembly process.

[0261] FIG. 20B is a cross-sectional view through the transducer along line B—B of FIG. 21A. The thickness of the adhesive layer can be in the range of about 0.0005 (0.013 mm) to about 0.001 inches (0.025 mm). The cover can have a thickness in the range of about 0.001 to about 0.003 inches.

[0262] FIGS. 21A and 21B illustrate another embodiment of the suspended coaxial transducer of the present invention. With reference to FIG. 21A, the transducer (904) is shown in perspective view formed inside an enclosure such as a thin shell or housing, which housing which has mounting flanges (914) extending proximally and distally from the transducer. FIG. 21B shows the transducer in transverse section. The transducer (904) is suspended over the tracking member (900) by the mounting flanges (914) which extend from the either end of the transducer (904). An air space (906) exists between the inner surface of the housing (920) that encapsulates the transducer (904) and the tracking member (900). The air space (906) extends to and may be more pronounced in the regions between the mounting flanges (914) and the tracking member (900), depending on the configuration of the mounting flanges.

[0263] The mounting flanges (914) may be formed in a variety of configurations, as long as they extend axially from the transducer and are capable of mounting to the tracking member (900) so as to suspend the transducer over the tracking member (900). For example, the flanges (914) may be centrally disposed and of a smaller outer diameter than the coated transducer, as illustrated in FIGS. 21A and 21B. Alternatively, the flanges may be of the same diameters or may have a larger inner diameter than the coated transducer. The flanges may also be disposed asymmetrically, for instance, extending from the top or bottom surfaces of the transducer. With respect to the method of constructing such support assemblies as herein shown and described by reference to the specific embodiments, the shapes provided may be imparted onto a starting “plug” or workpiece of material, such as by grinding or heat processing, or the support may be molded, laminated, cast, or otherwise formed as a “composite” of sorts wherein each region of the support is a subassembly that is connected to the others to form the support structure.

[0264] The mounting flanges (914) may also be mounted in a variety of structures (916) attached to the delivery member (900) on the proximal and distal sides of the transducer. One variation in the mounting structure (916) can be an end cap with a groove sized to receive the mounting flange, as shown in FIG. 21B. Such end cap can be made of a suitable plastic or elastomer (e.g., silicone, PET, etc.). Another variation of the mounting design is illustrated in FIG. 22, which shows a support sleeve and shrink-wrap cover. In this variation, the transducer (904) with molded coating (920) and flanges (914) is suspended over the tracking member (900) by a support sleeve (928) upon which the flanges (914) rest. The support sleeve (928) may have a groove for engaging the flange as shown. The transducer (904) can be secured by heat shrinking a covering sleeve (926) (e.g., PET) over the flanges (914), thereby maintaining the air gap (906) between the transducer (904) and the tracking member (900)—such resulting construction also beneficially provides a seal to prevent fluid from infiltrating into the airspace under the transducer. The mechanical joints formed by compressing the ends of the mounting flanges between the support sleeve (928) and the covering sleeve (926) supports the ends of the mounting flanges (914) with the transducer suspended between the resulting proximal and distal joints.

[0265] In accordance with another variation, as illustrated in FIG. 23, the mounting structure can include O-rings (922), upon which the flanges (914) rest, thereby suspending the transducer (904) above the tracking member (900), wherein the proximal flange is bonded with adhesive (924), preferably a flexible adhesive, to the tracking member proximal to the proximal O-ring and the distal flange is bonded with adhesive to the tracking member distal to the distal O-ring. Moreover, the transducer/housing assembly and flanges thus mounted by adhesive may be further secured by heat shrinking a plastic (e.g., polymeric) covering sleeve (926) over the flange (914). The shrink-wrap cover could be fused to the elastomeric adhesive (924) by heat or chemical process. In a variation, the entire suspended coaxial transducer assembly, including the flanges (914) could be covered with the shrink-wrap material (926) that is also bound by the adhesive. The assembly can also be dipped coated to form the outer covering.

[0266] The O-ring mounting variation has the advantage of preventing adhesive from running into the air gap, for example, when the assembly is heated in applying the shrink-wrap. Also, the elastic properties of the O-ring tend to push the flange tightly against the shrink-wrap outer cover. The O-rings also support the transducer about the tracking member during the assembly process (e.g., when applying the epoxy and heat shrinking) to hold the transducer in a generally concentric position relative to an axis of the tracking member (900) before the assembly cures.

[0267] The thin molded shell (920) that coats the transducer (904) and forms the flanges (914) is preferably made of a high temperature resistant elastomer, an in any event a material that may withstand temperatures up to about 200 degrees C. in the event the transducer is run at high power, such as at a power sufficient to ablate circumferential regions of tissue. The material may be a thermoset elastomer, such as urethane or silicone rubber. Alternatively, the material could be a thermoplastic polymer, such as polyurethane, PET, or any other polymeric thermoplastic known to those of skill in the art for manufacture of medical devices. The shell should have a Shore hardness of about 90 (scale A). However, the greater the unsupported distance along the flange between the mounting structure (e.g., the end cap, support sleeve or O-ring) and the transducer, the greater the flexibility of the flange. While high flexibility of the flanges is desirable for damping prevention, the stiffness of the flange material must nevertheless be sufficient to prevent the suspended transducer from bowing and contacting the tracking member. The stiffness can be increased by using a material of higher Shore hardness (e.g., a thermoplastic rather than silicone rubber) and/or by increasing the thickness of the flange.

[0268] Several methods of manufacturing the transducer with a thin coating of plastic or rubber (e.g., silicone or other elastomeric coatings) and axial flanges are disclosed herein. First, the housing could be injection molded about the transducer. The injection molding could be accomplished in at least two separate stages. Using silicone as an exemplary material, a base layer of silicone is placed beneath the transducer and axially to form the flanges, while the transducer is mounted on a base sleeve of silicone on a mandrel. When cured, the mandrel is removed, leaving the transducer coated on its upper surface with the silicone support cover the inner surfaces of the transducer. The outer coating and the inner sleeve of silicone desirably are joined, either by a fusion of the materials during the injection process or by heat or chemical processes, or by other means well known in the art. If an inner support is not used, the bottom surfaces next can be injection molded in similar manner. The two half molds can then be joined by heat or chemical process to form the complete shell. Instead of injection molding the second surface of the transducer, the half-coated transducer could be formed by dipping in a liquid elastomer, one or several times. Since the flange would be difficult to form by dipping, it would be preferred that the flange be injection molded. Alternatively, it may be desirable to use a transducer coated only on one surface (e.g., the inner surface). Lastly, the transducer coated with a thin shell may be made by dipping the transducer one or several times to achieve the desired thickness. A mandrel may be used to hold the transducer during the dipping process.

[0269] Another variation of the suspended coaxial transducer (904) is illustrated in FIG. 24 having injection molded end mounts (930). In this variation, the transducer is suspended over the tracking member (900) by fitting within grooves formed in injection molded end mounts (930). The grooves may be molded or formed during post-molding processing. The end mounts are molded to have an inside diameter of close to that of the outside diameter of the tracking member (900) so as to facilitate fastening to the tracking member (900) by adhesive or other means proximal and distal to the transducer. The end mounts also have an increased diameter in the mounting region, so as to engage the transducer within the mounting grooves at a fixed distance above the tracking member (900), thereby creating the desired air gap (906). The transducer may be secured within the end mount grooves by adhesive, fasteners, etc.

[0270] A mounting balloon variation of the suspended coaxial transducer is shown in FIG. 25A. In this variation, the transducer (904) is mounted on an expandable member or balloon (932) that creates a flexible mounting structure and an air gap (906) between the balloon (932) and the outer surface of the tracking member (900). The transducer (904) can be sealed to the balloon by elastomeric adhesive. In this variation, the electrical lead (933) to the inner conductive layer of the ultrasound transducer may be sealed using elastomeric adhesive between the balloon (932) and the inner layer of the transducer (904). In another variation, the adhesive can be conductive (e.g., contain silver) and a surface of the balloon can be coated with or formed by a conductive layer so as to provide an electrical path from a lead in contact with or embedded within the adhesive, through the conductive layer an to an inner electrode of the transducer to power the inner electrode.

[0271] With reference to FIG. 25B, there is shown a perspective view of one possible sequence of making the balloon mounted transducer. On the left side, a tubular balloon stock (932) is shown before inflation, having a layer of adhesive (934) applied to the outer surface. In the center, the transducer (904) is shown with the inner lead (933) in place. Next, the transducer (904) is inserted over the balloon (932). The distal region of the balloon is then closed and pressurized air or fluid is applied at the proximal end causing the balloon to inflate and press radially outward against the inner surface of the transducer. During this process, the balloon may be “cold blown” without the presence of heat as known in the art, or can be heated. In this latter process, the balloon is inflated while heating the balloon material to a glass transition temperature within a “capture tube.” The capture tube desirably has a diameter generally equal to an inner diameter of the transducer so that the formed balloon will have an outer diameter approximating the inner diameter of the transducer. In addition, the capture tube can be configured so as to produce a desired profile for neck sections of the balloon on either side of a central section on which the transducer will be mounted. In either a cold or heated process, the balloon is inflated to a size causing the adhesive to bond the interior surface of transducer against an exterior section of the balloon.

[0272] The adhesive bonds the outer surface of the balloon to the inner surface of the transducer; the bonding step may require heating. In heating process, the adhesive desirably can withstand the blowing temperatures, as one skilled in the art will readily appreciate. The inner lead is thereby fixed in contact with the inner surface of the transducer and exits through the adhesive seal between the balloon and the transducer.

[0273] The mounting construction illustrated in FIG. 25A can also be made by performing the balloon (either by a cold or heated blowing process) and subsequently placing the transducer over the inflated section of the balloon. Adhesive is placed between the balloon and the transducer, either by precoating the balloon and/or transducer with adhesive, or by injecting adhesive between the balloon and the transducer. The preformed balloon may dip coated with an elastomer (e.g., silicone).

[0274] When assembled, the transducer can be cover by an outer jacketing or cover, but need not be. Such coating or jacket can be formed in any of a variety of ways, including, for example, but without limitation, by a dipping process or by heat-shrinking a cover over the transducer and balloon assembly. The coating or jacket inhibits fluid within the anchoring balloon (822) (FIG. 16A) from seeping between the mounting balloon (932) and the transducer (904).

[0275] The mounting balloon (932) can have a fairly rigid structure and generally maintain its shape after the blowing process, or can collapse down after blowing. When assembled to the tracking member (900) (e.g., the catheter shaft) the collapse balloon is inflated and pressurized to assume its shape. A static air lock is formed by sealing the ends of the mounting balloon in a well known manner.

[0276] The mounting balloon, as apparent from the above description, can be formed of any of a variety of materials used to form catheter balloon, including those that are compliant and those that are non-compliant. For instance, a mounting balloon that holds its shape can be made of a relatively rigid plastic (e.g., a polymer) such as a polyethylene (“PE”; preferably linear low density or high density or blends thereof), polyolefin copolymer (“POC”), polyethylene terepthalate (“PET”), polyimide, PEBAX or a nylon material. A balloon assembled with a static air lock can be made of any of a variety of compliant and non-compliant materials, such as any of those identified herein.

[0277] While the above mounting constructions have been illustrated with reference to a cylindrical transducer, it is understood that these mounting constructions can be used with arcuate or flat transducer panels. Additionally, the transducer or transducer assembly (when formed by a plurality of transducer panels) need not extend entirely about the tracking member.

[0278] In such a case, as noted above, the catheter may be rotated through an arc or completely rotated, depending upon the application, to create the desired lesion pattern.

[0279] FIG. 26 illustrates another mounting arrangement for the ultrasound transducer (904) on the tracking member (900). This variation, however, does not suspend the transducer (904) from supports that attached to the tracking member on proximal and distal sides of the transducer. Rather, the mounting arrangement includes an elastomeric support (940) that in interposed between the ends of the transducer (904) and the tracking member (900).

[0280] As seen in FIG. 26, as well as in FIGS. 27, 28A and 28B, the support (940) has a generally tubular configuration. Each end of the support includes a flange (942) that has a thicker wall than a central section (944) of the support (940). The inner diameter of the support (940) generally matches the outer diameter of the tracking member (900), and the outer diameter of the flanges (944) generally matches the inner diameter of the transducer (904). The outer diameter of the central section (944) is smaller than the outer diameter of the flanges (942).

[0281] When assembled, the transducer is attached to the flanges (942) of the support (940) by a suitable adhesive or epoxy. The flanges (942) thus lie between the ends of the transducer (904) and the tracking member (900). The central section is spaced from the inner surface of the transducer (904) as a result of the generally “dumbbell-like” shape to form an air gap (946) between the support (940) and the transducer (904).

[0282] FIGS. 29A-29D illustrate a further design according to the invention wherein a cylindrical ultrasound transducer (1000) is mounted onto shaft (1052) of a delivery member (1050) via a support member (1020). Support member (1020) has two end portions (1022,1024) and an intermediate region (1026) therebetween. Transducer (1000) coaxially surrounds and rests on intermediate region (1026), whereas end portions (1022,1024) function as flanges by mounting onto underlying shaft (1052) without bridging across radial separation area (1010) between outer surface (1055) of shaft (1052) and inner surface (1006) of transducer (1000). In addition, each of end portions (1022,1024) includes an outer lip (1023,1025), respectively, which border ends (1002,1004) of transducer (1000), also respectively, and provide in one regard for the longitudinal stability of the transducer position on shaft (1052). In one further mode illustrated in FIG. 29D, outer jackets (1030,1040) can be secured over end portions (1022,1024) and onto shaft (1052) such as via adhesive fillets (1036,1046) and thereby affectively seal radial separation area (1010) from fluid ingress without covering transducer (1000). End portions (1022,1024) of support member (1020) also include inner lips (1023′,1025′) which rest on outer surface (1055) of shaft (1052) outside of the radial separation area (1010) and provide the “stand-offs” in order to ensure airbacking along radial separation area (1010).

[0283] As elsewhere disclosed herein, support member (1020) preferably is constructed of an elastomeric or at least flexible material in order to decrease damping, and is also preferably relatively heat resistant and non-degradable at temperatures around about 200 deg C. In addition, dimensions for the various features of support member (1020) include: outer diameter of surface (1055) of shaft (1052) of around about 0.050 inches; inner diameter of intermediate region (1026) of around about 0.060 inches; and inner diameter of transducer (1000) of around about 0.070 inches.

[0284] While particular detailed description has been herein provided for particular embodiments and variations according to the present invention, it is further understood that various modifications and improvements may be made by one of ordinary skill according to this disclosure and without departing from the broad scope of the invention.

[0285] It is further contemplated that the embodiments shown and described herein may be combined, assembled together, or where appropriate substituted for the various features and embodiments which are disclosed in the following co-pending provisional and non-provisional U.S. Patent Applications: the co-pending non-provisional U.S. Patent Application for “FEEDBACK APPARATUS AND METHOD FOR ABLATION AT PULMONARY VEIN OSTIUM”, filed on the same day as this Application, and claiming priority to Provisional U.S. Patent Application No. 60/122,571, filed on Mar. 2, 1999; the co-pending non-provisional U.S. Patent Application for “CIRCUMFERENTIAL ABLATION DEVICE ASSEMBLY AND METHODS OF USE AND MANUFACTURE PROVIDING AN ABLATIVE CIRCUMFERENTIAL BAND ALONG AN EXPANDABLE MEMBER”, filed on the same day as this Application, and which claims priority to Provisional U.S. Application No. 60/125,509, filed Mar. 19, 1999; the co-pending non-provisional U.S. Patent Application for “CIRCUMFERENTIAL ABLATION DEVICE ASSEMBLY AND METHODS OF USE AND MANUFACTURE PROVIDING AN ABLATIVE CIRCUMFERENTIAL BAND ALONG AN EXPANDABLE MEMBER”, filed on the same day as this Application, and which claims priority to Provisional U.S. Patent Application No. 60/125,928, filed Mar. 23, 1999; co-pending Provisional U.S. Patent Application No. 60/133,610 for “BALLOON ANCHOR WIRE”, filed May 11, 1999; the co-pending non-provisional U.S. Patent Application for “TISSUE ABLATION DEVICE ASSEMBLY AND METHOD FOR ELECTRICALLY ISOLATING A PULMONARY VEIN OSTIUM FROM A POSTERIOR LEFT ATRIAL WALL”, filed on the same day as this Application, and which claims priority to Provisional U.S. Patent Application No. 60/133,677, filed May 11, 1999; and co-pending Provisional U.S. Patent Application Ser. No. 60/133,807 for “CATHETER POSITIONING SYSTEM”, filed May 11, 199. The disclosures of these references are herein incorporated in their entirety by reference thereto.

[0286] In addition, a circumferential ablation device assembly constructed with a mounted ultrasound ablation element according to the present invention may be used in combination with other linear ablation assemblies and methods, and various related components or steps of such assemblies or methods, respectively, in order to form a circumferential conduction block adjunctively to the formation of long linear lesions, such as in a less-invasive “maze”-type procedure. Examples of such assemblies and methods related to linear lesion formation and which are contemplated in combination with the presently disclosed embodiments are shown and described in the following additional co-pending U.S. Patent Applications: U.S. Ser. No. 08/853,861 entitled “TISSUE ABLATION DEVICE AND METHOD OF USE” filed by Michael Lesh, M.D. on May 9, 1997; U.S. Ser. No. 09/260,316 for “TISSUE ABLATION SYSTEM AND METHOD FOR FORMING LONG LINEAR LESION” to Langberg et al., filed May 1, 1999; and U.S. Ser. No. 09/073,907 for “TISSUE ABLATION DEVICE WITH FLUID IRRIGATED ELECTRODE”, to Alan Schaer et al., filed May 6, 1998. The disclosures of these references are herein incorporated in their entirety by reference thereto.

[0287] In addition, one of ordinary skill may make other obvious or insubstantial modifications or improvements to the specific embodiments herein shown and described based upon this disclosure without departing from the scope of the invention as defined by the claims which follow.

Claims

What is claimed is:

1. A tissue ablation system, comprising:

an elongate body with a proximal end portion, and a distal end portion having a longitudinal axis and a radial axis and which is adapted to be positioned within a body space of a patient by manipulating the proximal end portion; and

an ultrasound ablation element suspended on the distal end portion with a radial separation that defines a radial separation area between the ultrasound ablation element and the distal end portion, and without a support structure bridging across the radial separation area between the ultrasound ablation element and the distal end portion.

2. The system of claim 1, wherein a gas is captured within the radial separation area.

3. The system of claim 2, wherein a substantial portion of the radial separation area is sealed to substantially prevent an external fluid from entering the radial separation area.

4. The system of claim 1, wherein said ultrasound ablation element is adapted to ablate a circumferential region of tissue at a location where a pulmonary vein extends from an atrium in a patient.

5. The system of claim 1, wherein the ultrasound ablation element comprises a cylindrical ultrasound transducer having an inner surface forming an inner bore which is positioned over and around the distal end portion, and the radial separation area is located between the inner surface and the distal end portion.

6. The system of claim 1, wherein said ultrasound ablation element comprises a piezoceramic ultrasound transducer.

7. The system of claim 1, wherein said ultrasound ablation element comprises an array of ultrasound transmissive panels.

8. The system of claim 1, further comprising an external cover layer which is disposed around said ultrasound ablation element and distal end portion such that the ultrasound ablation element is positioned between the external cover layer and the distal end portion.

9. The system of claim 8, wherein said external cover layer comprises an adhesive.

10. The system of claim 8, wherein said external cover layer comprises an external cover member with an inner surface which surrounds the ultrasound ablation element and also an adhesive layer between the inner surface and the ultrasound ablation element.

11. The system of claim 8, wherein the external cover layer has a distal end portion which is secured to the distal end portion of the elongate body distally of the ultrasound ablation element, and also has a proximal end portion which is secured to the distal end portion of the elongate body proximally of the ultrasound ablation element.

12. The system of claim 8, wherein said external cover layer comprises a polymer.

13. The system of claim 1, wherein the ultrasound ablation element comprises first and second end portions, first and second mounting flanges extend axially from said first and second end portions, respectively, relative to the longitudinal axis, and the first and second mounting flanges are secured to the distal end portion at first and second locations, respectively, which are outside of the radial separation area.

14. The system of claim 13, further comprising a first end cap secured to the first mounting flange and also to the distal end portion at the first location, and a second end cap secured to the second mounting flange and also to the distal end portion at the second location.

15. The delivery member of claim 14, wherein at least one of said first and second end caps comprises a plastic or an elastomer.

16. The system of claim 13, further comprising a first O-ring mounted radially between the first mounting flange and the distal end portion at the first location, and a second O-ring mounted radially between the second mounting flange and the distal end portion at the second location.

17. The system of claim 13, wherein each of the first and second mounting flanges comprises a first end portion having a recess which engages the ultrasound ablation element and also a second end portion secured to the distal end portion.

18. The system of claim 13, wherein the first and second mounting flanges are connected.

19. The delivery member of claim 1, further comprising a tubular member having first and second end portions and an interior portion therebetween with an interior surface and an exterior surface, wherein the first and second end portions are secured to first and second locations, respectively, and the ultrasound ablation element is secured to the exterior surface of the intermediate portion.

20. The system of claim 1, further comprising an expandable member located along the distal end portion.

21. The system of claim 20, wherein the expandable member comprises an outer wall which is adjustable between a radially collapsed position and a radially expanded position, and the ultrasound ablation element is located radially between the outer wall and the distal end portion and is adapted to ultrasonically couple to tissue radially engaged by the outer wall in the radially expanded position.

22. The system of claim 21, wherein the expandable member is adapted to engage a circumferential region of tissue at a location where a pulmonary vein extends from an atrium in a patient, such that the ultrasound ablation element is adapted to ablate the circumferential region of tissue.

23. The system of claim 1, wherein the ultrasound ablation element is mounted onto the distal end portion at a first location, and further comprising a mounting assembly coupled to the ultrasound ablation element and also to the distal end portion at at least one other location which is outside of the radial separation area, such that the mounting assembly mounts the ultrasound ablation element onto the distal end portion without extending radially across the radial separation area between the distal end portion and the ultrasound ablation element.

24. An ultrasound transducer assembly for use with a delivery member in a tissue ablation system, comprising:

a cylindrical ultrasound transducer having a first end portion, a second end portion, a longitudinal axis extending between the first and second end portions, an outer surface, an inner surface that defines an inner bore extending along the longitudinal axis; and

a mounting assembly coupled to cylindrical ultrasound transducer with a first mounting flange extending longitudinally from the first end portion and a second mounting flange extending longitudinally from the second end portion,

wherein the first and second mounting flanges are adapted to be secured to the delivery member in order to mount the cylindrical ultrasound transducer to the delivery member.

25. The assembly of claim 24, wherein the first and second mounting flanges are connected.

26. The assembly of claim 25, wherein the mounting assembly comprises a mounting member having first and second end portions with an intermediate portion therebetween, an inner surface, and an outer surface, wherein the intermediate portion is coupled to the cylindrical ultrasound transducer and the first and second end portions extend beyond the cylindrical ultrasound transducer relative to the longitudinal axis.

27. The assembly of claim 26, wherein the inner surface along the intermediate portion at least in part surrounds the cylindrical ultrasound transducer.

28. The assembly of claim 26, wherein the cylindrical ultrasound transducer surrounds at least a part of the outer surface along the intermediate portion.

29. The assembly of claim 26, wherein the mounting member along the intermediate portion further comprises an outer layer and an inner layer with a cylindrical space enclosed therebetween, and the cylindrical ultrasound transducer is positioned within the cylindrical space.

30. The assembly of claim 24, wherein the cylindrical ultrasound transducer has an outer diameter, the first and second mounting flanges comprise first and second tubular members, respectively, and each tubular member has a reduced diameter section with an inner diameter which is less than the outer diameter of the cylindrical ultrasound transducer and which is adapted to be secured around the delivery member.

31. A method for manufacturing a tissue ablation device assembly, comprising:

mounting a first mounting flange to a first end portion of a cylindrical ultrasound transducer;

mounting a second mounting flange to a second end portion of an ultrasound transducer;

mounting the first mounting flange to a first location along a distal end portion of a delivery member; and

mounting the second mounting flange to a second location along the distal end portion of the delivery member,

wherein the cylindrical ultrasound transducer is located along the distal end portion of the delivery member between and without extending over the first and second locations.

32. The method of claim 31, further comprising mounting the first mounting flange to the cylindrical ultrasound transducer before mounting the first mounting flange to the delivery member.

33. The method of claim 31, further comprising mounting both of the first and second mounting flanges to the cylindrical ultrasound transducer before mounting the flanges to the delivery member.

34. The method of claim 31, further comprising mounting the first mounting flange to the delivery member before mounting the first mounting flange to the cylindrical ultrasound transducer.

35. The method of claim 31, wherein the first and second mounting flanges are connected by an intermediate member, and further comprising mounting the mounting flanges to the cylindrical ultrasound transducer by mounting the intermediate member to the cylindrical ultrasound transducer.

36. A method for manufacturing an ultrasound transducer assembly for use with a delivery member in a tissue ablation system, comprising:

mounting a first mounting flange to a first end portion of a cylindrical ultrasound transducer having a longitudinal axis; and

mounting a second mounting flange to a second end portion of the cylindrical ultrasound transducer,

wherein the first and second mounting flanges extend from the first and second end portions, respectively, of the cylindrical ultrasound transducer relative to the longitudinal axis such that the mounting flanges are adapted to be secured to the delivery member to thereby mount the cylindrical ultrasound transducer to the delivery member.

37. The method of claim 36, further comprising connecting the first and second mounting flanges along the cylindrical ultrasound transducer.

38. The method of claim 36, further comprising mounting the first mounting flange to the ultrasound transducer before mounting the second mounting flange to the ultrasound transducer.

39. The method of claim 36, further comprising mounting the first and second mounting flanges to the ultrasound transducer such that the mounting flanges are connected.

40. The method of claim 39, further comprising mounting the mounting flanges to the cylindrical ultrasound transducer by substantially enclosing the cylindrical ultrasound transducer within a housing and extending the mounting flanges from the housing beyond the first and second end portions.

41. The method of claim 40, further comprising forming the flanges integrally with at least a portion of the housing.

42. The method of claim 36, further comprising forming the cylindrical ultrasound transducer from an array of ultrasound transducer panels.

43. The method of claim 42, farther comprising adapting each of the array of ultrasound transducer panels to be individually actuatable.

44. The method of claim 36, wherein the first mounting flange comprises a tubular member with first and second end portions, and further comprising mounting the first mounting flange onto the cylindrical ultrasound transducer by mounting the first end portion of the tubular member to a substantial portion of a circumference of the first end portion of the cylindrical ultrasound transducer, such that the second end portion of the tubular member extends from the first end portion of the cylindrical ultrasound transducer.

Patent Citations (229)

Patent	Date	Inventor	Cited By
US3781781(A)	1973-12-01	Groves, Jr.	Applicant
US3938502(A)	1976-02-01	Bom	Applicant
US4033031(A)	1977-07-01	Ballew	Applicant
US4117836(A)	1978-10-01	Erickson	Applicant
US4316472(A)	1982-02-01	Mirowski et al.	Applicant
US4411266(A)	1983-10-01	Cosman	Applicant
US4449528(A)	1984-05-01	Auth et al.	Applicant
US4522205(A)	1985-06-01	Taylor et al.	Applicant
US4569801(A)	1986-02-01	Molloy et al.	Applicant
US4641649(A)	1987-02-01	Walinsky et al.	Applicant
US4660571(A)	1987-04-01	Hess et al.	Applicant
US4662368(A)	1987-05-01	Hussein et al.	Applicant
US4669469(A)	1987-06-01	Gifford, III et al.	Applicant
US4672962(A)	1987-06-01	Hershenson	Applicant
US4673563(A)	1987-06-01	Berne et al.	Applicant
US4676258(A)	1987-06-01	Inokuchi et al.	Applicant
US4699147(A)	1987-10-01	Chilson et al.	Applicant
US4757820(A)	1988-07-01	Itoh	Applicant
US4762129(A)	1988-08-01	Bonzel	Applicant
US4790311(A)	1988-12-01	Ruiz	Applicant
US4807620(A)	1989-02-01	Strul et al.	Applicant
US4841977(A)	1989-06-01	Griffith et al.	Applicant
US4882777(A)	1989-11-01	Narula	Applicant
US4898591(A)	1990-02-01	Jang et al.	Applicant
US4917096(A)	1990-04-01	Englehart et al.	Applicant
US4924863(A)	1990-05-01	Sterzer	Applicant
US4936281(A)	1990-06-01	Stasz	Applicant
US4940064(A)	1990-07-01	Desai	Applicant
US4945912(A)	1990-08-01	Langberg	Applicant
US4951677(A)	1990-08-01	Crowley et al.	Applicant
US4976711(A)	1990-12-01	Parins et al.	Applicant
US4998933(A)	1991-03-01	Eggers et al.	Applicant
US5000185(A)	1991-03-01	Yock	Applicant
US5002059(A)	1991-03-01	Crowley et al.	Applicant
US5035694(A)	1991-07-01	Kasprzyk et al.	Applicant
US5078717(A)	1992-01-01	Parins et al.	Applicant
US5078736(A)	1992-01-01	Behl	Applicant
US5090958(A)	1992-02-01	Sahota	Applicant
US5104393(A)	1992-04-01	Isner et al.	Applicant
US5131397(A)	1992-07-01	Crowley	Applicant
US5147355(A)	1992-09-01	Friedman et al.	Applicant
US5156157(A)	1992-10-01	Valenta, Jr. et al.	Applicant
US5178618(A)	1993-01-01	Kandarpa	Applicant
US5186177(A)	1993-02-01	O'Donnell et al.	Applicant
US5190540(A)	1993-03-01	Lee	Applicant
US5195990(A)	1993-03-01	Weldon	Applicant
US5209229(A)	1993-05-01	Gilli	Applicant
US5222501(A)	1993-06-01	Ideker et al.	Applicant
US5226430(A)	1993-07-01	Spears et al.	Applicant
US5228442(A)	1993-07-01	Imran	Applicant
US5231995(A)	1993-08-01	Desai	Applicant
US5255679(A)	1993-10-01	Imran	Applicant
US5263493(A)	1993-11-01	Avitall	Applicant
US5281215(A)	1994-01-01	Milder	Applicant
US5292321(A)	1994-03-01	Lee	Applicant
US5293868(A)	1994-03-01	Nardella	Applicant
US5293869(A)	1994-03-01	Edwards et al.	Applicant
US5295484(A)	1994-03-01	Marcus et al.	Applicant
US5300085(A)	1994-04-01	Yock	Applicant
US5313943(A)	1994-05-01	Houser et al.	Applicant
US5324255(A)	1994-06-01	Passafaro et al.	Applicant
US5324284(A)	1994-06-01	Imran	Applicant
US5325860(A)	1994-07-01	Seward et al.	Applicant
US5331966(A)	1994-07-01	Bennett et al.	Applicant
US5342292(A)	1994-08-01	Nita et al.	Applicant
US5344435(A)	1994-09-01	Turner et al.	Applicant
US5345936(A)	1994-09-01	Pomeranz et al.	Applicant
US5345940(A)	1994-09-01	Seward et al.	Applicant
US5348554(A)	1994-09-01	Imran et al.	Applicant
US5368035(A)	1994-11-01	Hamm et al.	Applicant
US5368557(A)	1994-11-01	Nita et al.	Applicant
US5368558(A)	1994-11-01	Nita	Applicant
US5370678(A)	1994-12-01	Edwards et al.	Applicant
US5372138(A)	1994-12-01	Crowley et al.	Applicant
US5385148(A)	1995-01-01	Lesh et al.	Applicant
US5385544(A)	1995-01-01	Edwards et al.	Applicant
US5391197(A)	1995-02-01	Burdette et al.	Applicant
US5409000(A)	1995-04-01	Imran	Applicant
US5411524(A)	1995-05-01	Rahul	Applicant
US5421338(A)	1995-06-01	Crowley et al.	Applicant
US5423808(A)	1995-06-01	Edwards et al.	Applicant
US5423811(A)	1995-06-01	Imran et al.	Applicant
US5427119(A)	1995-06-01	Swartz et al.	Applicant
US5433708(A)	1995-07-01	Nichols et al.	Applicant
US5437664(A)	1995-08-01	Cohen et al.	Applicant
US5447509(A)	1995-09-01	Mills et al.	Applicant
US5449380(A)	1995-09-01	Chin	Applicant
US5454373(A)	1995-10-01	Koger et al.	Applicant
US5456682(A)	1995-10-01	Edwards et al.	Applicant
US5465716(A)	1995-11-01	Avitall	Applicant
US5474530(A)	1995-12-01	Passafaro et al.	Applicant
US5484400(A)	1996-01-01	Edwards et al.	Applicant
US5487385(A)	1996-01-01	Avitall	Applicant
US5496312(A)	1996-03-01	Klicek	Applicant
US5496346(A)	1996-03-01	Horzewski et al.	Applicant
US5497119(A)	1996-03-01	Tedrow et al.	Applicant
US5497774(A)	1996-03-01	Swartz et al.	Applicant
US5501227(A)	1996-03-01	Yock	Applicant
US5505702(A)	1996-04-01	Arney	Applicant
US5505730(A)	1996-04-01	Edwards	Applicant
US5509900(A)	1996-04-01	Kirkman	Applicant
US5522873(A)	1996-06-01	Jackman et al.	Applicant
US5545161(A)	1996-08-01	Imran	Applicant
US5545193(A)	1996-08-01	Fleischman et al.	Applicant
US5549661(A)	1996-08-01	Kordis et al.	Applicant
US5558672(A)	1996-09-01	Edwards et al.	Applicant
US5562720(A)	1996-10-01	Stern et al.	Applicant
US5564440(A)	1996-10-01	Swartz et al.	Applicant
US5569241(A)	1996-10-01	Edwards	Applicant
US5571088(A)	1996-11-01	Lennox et al.	Applicant
US5571159(A)	1996-11-01	Alt	Applicant
US5575766(A)	1996-11-01	Swartz et al.	Applicant
US5575772(A)	1996-11-01	Lennox	Applicant
US5575788(A)	1996-11-01	Baker et al.	Applicant
US5575810(A)	1996-11-01	Swanson et al.	Applicant
US5582609(A)	1996-12-01	Swanson et al.	Applicant
US5588432(A)	1996-12-01	Crowley	Applicant
US5606974(A)	1997-03-01	Castellano et al.	Applicant
US5607422(A)	1997-03-01	Smeets et al.	Applicant
US5617854(A)	1997-04-01	Munsif	Applicant
US5620479(A)	1997-04-01	Diederich	Applicant
US5630837(A)	1997-05-01	Crowley	Applicant
US5642736(A)	1997-07-01	Avitall	Applicant
US5645082(A)	1997-07-01	Sung et al.	Applicant
US5658278(A)	1997-08-01	Imran et al.	Applicant
US5673695(A)	1997-10-01	McGee et al.	Applicant
US5676662(A)	1997-10-01	Fleischhacker et al.	Applicant
US5683445(A)	1997-11-01	Swoyer	Applicant
US5685322(A)	1997-11-01	Sung et al.	Applicant
US5685839(A)	1997-11-01	Edwards et al.	Applicant
US5687723(A)	1997-11-01	Avitall	Applicant
US5687729(A)	1997-11-01	Schaetzle	Applicant
US5688267(A)	1997-11-01	Panescu et al.	Applicant
US5690611(A)	1997-11-01	Swartz et al.	Applicant
US5693078(A)	1997-12-01	Desai et al.	Applicant
US5697925(A)	1997-12-01	Taylor	Applicant
US5697927(A)	1997-12-01	Imran et al.	Applicant
US5702438(A)	1997-12-01	Avitall	Applicant
US5715818(A)	1998-02-01	Swartz et al.	Applicant
US5716389(A)	1998-02-01	Walinsky et al.	Applicant
US5718231(A)	1998-02-01	Dewhurst et al.	Applicant
US5718241(A)	1998-02-01	Ben-Haim et al.	Applicant
US5718701(A)	1998-02-01	Shai et al.	Applicant
US5720775(A)	1998-02-01	Larnard	Applicant
US5722401(A)	1998-03-01	Pietroski et al.	Applicant
US5722403(A)	1998-03-01	McGee et al.	Applicant
US5722963(A)	1998-03-01	Lurie et al.	Applicant
US5725494(A)	1998-03-01	Brisken	Applicant
US5725512(A)	1998-03-01	Swartz et al.	Applicant
US5728062(A)	1998-03-01	Brisken	Applicant
US5730127(A)	1998-03-01	Avitall	Applicant
US5730704(A)	1998-03-01	Avitall	Applicant
US5733315(A)	1998-03-01	Burdette et al.	Applicant
US5735280(A)	1998-04-01	Sherman et al.	Applicant
US5735811(A)	1998-04-01	Brisken	Applicant
US5735846(A)	1998-04-01	Panescu et al.	Applicant
US5741249(A)	1998-04-01	Moss et al.	Applicant
US5741320(A)	1998-04-01	Thornton et al.	Applicant
US5743870(A)	1998-04-01	Edwards	Applicant
US5743903(A)	1998-04-01	Stern et al.	Applicant
US5749880(A)	1998-05-01	Banas et al.	Applicant
US5755663(A)	1998-05-01	Larsen et al.	Applicant
US5755664(A)	1998-05-01	Rubenstein	Applicant
US5755715(A)	1998-05-01	Stern et al.	Applicant
US5755760(A)	1998-05-01	Maguire et al.	Applicant
US5769846(A)	1998-06-01	Edwards et al.	Applicant
US5782239(A)	1998-07-01	Webster, Jr.	Applicant
USRE35880(E)	1998-08-01	Waldman et al.	Applicant
US5797877(A)	1998-08-01	Hamilton et al.	Applicant
US5797903(A)	1998-08-01	Swanson et al.	Applicant
US5797905(A)	1998-08-01	Fleischman et al.	Applicant
US5800378(A)	1998-09-01	Edwards et al.	Applicant
US5800379(A)	1998-09-01	Edwards	Applicant
US5800413(A)	1998-09-01	Swartz et al.	Applicant
US5800428(A)	1998-09-01	Nelson et al.	Applicant
US5800429(A)	1998-09-01	Edwards	Applicant
US5807249(A)	1998-09-01	Qin et al.	Applicant
US5807308(A)	1998-09-01	Edwards	Applicant
US5807391(A)	1998-09-01	Wijkamp	Applicant
US5807395(A)	1998-09-01	Mulier et al.	Applicant
US5824046(A)	1998-10-01	Smith et al.	Applicant
US5846218(A)	1998-12-01	Brisken et al.	Applicant
US5851232(A)	1998-12-01	Lois	Applicant
US5928279(A)	1999-07-01	Shannon et al.	Applicant
US5938660(A)	1999-08-01	Swartz et al.	Applicant
US5971983(A)	1999-10-01	Lesh	Applicant
US6012457(A)	2000-01-01	Lesh	Applicant
US6023638(A)	2000-02-01	Swanson	Applicant
US6024739(A)	2000-02-01	Ponzi et al.	Applicant
US6024740(A)	2000-02-01	Lesh et al.	Applicant
US6064902(A)	2000-05-01	Haissaguerre et al.	Applicant
US6071279(A)	2000-06-01	Whayne et al.	Applicant
US6071281(A)	2000-06-01	Burnside et al.	Applicant
US6117101(A)	2000-09-01	Diederich et al.	Applicant
US6152920(A)	2000-11-01	Thompson et al.	Applicant
US6176842(B1)	2001-01-01	Tachibana et al.	Applicant
US6210356(B1)	2001-04-01	Anderson et al.	Applicant
US6290697(B1)	2001-09-01	Tu et al.	Examiner
US6305378(B1)	2001-10-01	Lesh	Applicant
EP623360	1994-02-01		Applicant
WO93/00958	1993-01-01		Applicant
WO93/08755	1993-05-01		Applicant
WO93/16632	1993-09-01		Applicant
WO93/20767	1993-10-01		Applicant
WO93/20770	1993-10-01		Applicant
WO93/20886	1993-10-01		Applicant
WO94/00050	1994-01-01		Applicant
WO94/21165	1994-09-01		Applicant
WO94/21167	1994-09-01		Applicant
WO94/21168	1994-09-01		Applicant
WO95/10318	1995-04-01		Applicant
WO95/10319	1995-04-01		Applicant
WO95/10321	1995-04-01		Applicant
WO95/19738	1995-07-01		Applicant
WO96/00036	1996-01-01		Applicant
WO96/10961	1996-04-01		Applicant
WO96/26675	1996-09-01		Applicant
WO96/32885	1996-10-01		Applicant
WO96/32897	1996-10-01		Applicant
WO97/32525	1997-09-01		Applicant
WO97/37607	1997-10-01		Applicant
WO97/45156	1997-12-01		Applicant
WO98/02201	1998-01-01		Applicant
WO98/26724	1998-06-01		Applicant
WO95/49957	1998-11-01		Applicant
WO99/00064	1999-01-01		Applicant
WO99/00064	1999-01-01		Applicant
WO99/02096	1999-01-01		Applicant
WO/07508	2000-02-01		Applicant

Non-Patent Literature (14)

Aug. 25, 2000, PCT International Search Report.Applicant
Hindricks, et al. “IX Nonpharmacologic Management Catheter Ablation.” Current Management of Arrythmias.Applicant
Jais, et al. “Biatrial Dimensions Relevant to Catheter Ablation.” NASPE 17th Annua Scientific Sessions Abstract. Dec., 1995.Applicant
Diederich, et al. “Induction of Hyperthermia using an Intracavitary Multielement Ultrasonic Applicator.” Transactions in Biomedical Engineering, vol. 36, No. 4, Apr. 1989.Applicant
Diederich, et al. The Development of Intracavitary Ultrasonic Applicators for Hyperthermia: A Design and Experimental Study. Medical Physics, Jul./Aug., 1990.Applicant
McMath, et al. “Percutaneous Laser Balloon Coagulation of Accessory Pathways.” Diagnostic and Therapeutic Cardiovascular Interventions, 1991.Applicant
Cox et al., “The Surgical Treatment of Atrial Fibrillation: I. Summary of the current concepts of the mechanisms of atrial flutter and atrial fibrillation.” The Journal of Thoracic and Cardiovascular Surgery, pp. 402-405, 1991.Applicant
Cox, “The surgical treatment of atrial fibrillation: IV. Surgical technique,” The Journal of Thoracic and Cardiovascular Surgery, pp. 584-592, 1991.Applicant
Schuger, et al. Long Term Effects of Percutaneous Laser Balloon Ablation from the Canine Coronary Sinus. Circulation, vol. 86, No. 3, Sep., 1992.Applicant
Avitall, et al. “Physics and Engineering of Transcatheter Cardiac Tissue Ablation.” JACC, vol. 22, No. 3, Sep. 1993.Applicant
Fram et al. “Feasibility of Radiofrequency Powered, Thermal Balloon Ablation of Atrioventricular Bypass Tracts Via the Coronary Sinus: In Vivo Canine Studies,” Pace, vol. 18, pp. 1518-1530, Aug. 1995.Applicant
Sueda et al., “Simple left atrial procedure for chronic atrial fibrillation associated with mitral valve disease” Ann Thorac Surg 62:1796-1800 (1996).Applicant
Haissaguerre et al., “Right and Left Atrial Radiofrequency Catheter Therapy of Paroxysmal Atrial Fibrillation,” Journal of Cardiovascular Electrophysiology, vol. 7, No. 12, pp. 1132-1144, Dec. 1996.Applicant
Jais et al., “A Focal Source of Atrial Fibrillation Treated by Discrete Radiofrequency Ablation,” Circulation, vol. 95, No. 3, pp. 572-576, Feb. 4, 1997.Applicant

Abstract